+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 10744

Chapter 10744 contains a list of PDF Full Texts available from EurekaMag.





Malik, A.H.; Prasad, P.; Saboorian, M.H.; Thiele, D.L.; Malet, P.F., 2000:
Hepatic injury due to troglitazone

Shibata, M.; Hirota, M.; Ogawa, M., 2002:
Hepatic injury induced by interleukin-18 administration: importance of preceding priming effect

Choi-Miura, N.H.; Otsuyama, K.; Sano, Y.; Saito, K.; Takahashi, K.; Tomita, M., 2001:
Hepatic injury-specific conversion of mouse plasma hyaluronan binding protein to the active hetero-dimer form

Dong, H.; Morral, N.; Mcevoy, R.; Meseck, M.; Thung, S.N.; Woo, S.L.C., 2001:
Hepatic insulin expression improves glycemic control in type 1 diabetic rats

Dong, H.; Woo, S.L.C., 2001:
Hepatic insulin production for type 1 diabetes

Hardin, D.S.; LeBlanc, A.; Para, L.; Seilheimer, D.K., 1999:
Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis

Santibanez-Gallerani, A.S.; Barber, A.E.; Williams, S.J.; Zhao, Y.; Shires, G.T., 2000:
Hepatic integrity dependent on matrix metalloproteinase inhibition, not tumor necrosis factor alpha or different bleeding rates

Morris, D.L.; Jourdan, J-L.; Finlay, I.; Gruenberger, T.; The, M.P.; Pourgholami, M.H., 2002:
Hepatic intra-arterial injection of 1,25-dihydroxyvitamin D3 in lipiodol: Pilot study in patients with hepatocellular carcinoma

Jourdan, J.L.; Akhter, J.; Bowrey, P.; Pourgholami, M.; Morris, D.L., 2000:
Hepatic intra-arterial injection of lipiodol-1,25-dihydroxyvitamin D3 for hepatocellular carcinoma in rats

de Baere, T.; Taourel, P.; Tubiana, J.M.; Kuoch, V.; Ducreux, M.; Lumbroso, J.; Roche, A.J., 1999:
Hepatic intraarterial 131I iodized oil for treatment of hepatocellular carcinoma in patients with impeded portal venous flow

Burns, S.P.; Murphy, H.C.; Iles, R.A.; Bailey, R.A.; Cohen, R.D., 2000:
Hepatic intralobular mapping of fructose metabolism in the rat liver

Ferrari, T.C.A.; Araújo, M.G.; Ribeiro, M.M.F., 2002:
Hepatic involvement in lepromatous leprosy

Younossi, Z.M.; Gramlich, T.; Bacon, B.R.; Matteoni, C.A.; Boparai, N.; O'Neill, R.; McCullough, A.J., 1999:
Hepatic iron and nonalcoholic fatty liver disease

Angelucci, E.; Brittenham, G.M.; Mclaren, C.E.; Ripalti, M.; Baronciani, D.; Giardini, C.; Galimberti, M.; Polchi, P.; Lucarelli, G., 2000:
Hepatic iron concentration and total body iron stores in thalassemia major

Telfer, P.T.; Prestcott, E.; Holden, S.; Walker, M.; Hoffbrand, A.V.; Wonke, B., 2000:
Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major

Bonkovsky, H.L.; Rubin, R.B.; Cable, E.E.; Davidoff, A.; Rijcken, T.H.; Stark, D.D., 1999:
Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques

Kim, M.J.; Mitchell, D.G.; Ito, K.; Hann, H.W.L.; Park, Y.N.; Kim, P.N., 2001:
Hepatic iron deposition on MR imaging in patients with chronic liver disease: Correlation with serial serum ferritin concentration

Sievert, W.; Pianko, S.; Warner, S.; Bowden, S.; Simpson, I.; Bowden, D.; Locarnini, S., 2002:
Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major

Hellman, N.E.; Schaefer, M.; Gehrke, S.; Stegen, P.; Hoffman, W.J.; Gitlin, J.D.; Stremmel, W., 2000:
Hepatic iron overload in aceruloplasminaemia

Rouault, T.A., 2003:
Hepatic iron overload in alcoholic liver disease: why does it occur and what is its role in pathogenesis?

Brown, K.E.; Khan, C.M.; Zimmerman, M.B.idget; Brunt, E.M., 2003:
Hepatic iron overload in blacks and whites: A comparative autopsy study

Ng, P.C.; Lam, C.W.; Lee, C.H.; To, K.F.; Fok, T.F.; Chan, I.H.; Wong, E., 2001:
Hepatic iron storage in very low birthweight infants after multiple blood transfusions

Lhuillier, F.; Parmantier, P.; Goudable, J.; Crova, P.; Delafosse, B.; Annat, G.; Cespuglio, R.; Viale, J.Paul., 2003:
Hepatic ischemia is associated with an increase in liver parenchyma nitric oxide that is in part enzyme-independent

Teoh, N.C.; Farrell, G.C., 2003:
Hepatic ischemia reperfusion injury: Pathogenic mechanisms and basis for hepatoprotection

Doi, K.; Horiuchi, T.; Uchinami, M.; Tabo, T.; Kimura, N.; Yokomachi, J.; Yoshida, M.; Tanaka, K., 2002:
Hepatic ischemia-reperfusion promotes liver metastasis of colon cancer

Kretzschmar, M.; Krüger, A.; Schirrmeister, W., 2003:
Hepatic ischemia-reperfusion syndrome after partial liver resection (LR): hepatic venous oxygen saturation, enzyme pattern, reduced and oxidized glutathione, procalcitonin and interleukin-6

Hur, G.M.; Ryu, Y.S.; Yun, H.Y.; Jeon, B.H.; Kim, Y.M.; Seok, J.H.; Lee, J.H., 1999:
Hepatic ischemia/reperfusion in rats induces iNOS gene transcription by activation of NF-kappaB

Teoh, N.; Dela Pena, A.; Farrell, G., 2002:
Hepatic ischemic preconditioning in mice is associated with activation of NF-kappaB, p38 kinase, and cell cycle entry

Gollapudi, B.B.; Jackson, K.M.; Stott, W.T., 1998:
Hepatic lacI and cII mutation in transgenic (lambdaLIZ) rats treated with dimethylnitrosamine

Ward, J.; Chen, F.; Guthrie, J.A.; Wilson, D.; Lodge, J.P.; Wyatt, J.I.; Robinson, P.J., 2000:
Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternative-free response receiver operating characteristic analysis

Ward, J.; Naik, K.S.; Guthrie, J.A.; Wilson, D.; Robinson, P.J., 1999:
Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis

Fiegel, H.C.; Kluth, J.; Lioznov, M.V.; Holzhuter, S.; Fehse, B.; Zander, A.R.; Kluth, D., 2003:
Hepatic lineages isolated from developing rat liver show different ways of maturation

Shohet, R.V.; Vega, G.L.; Anwar, A.; Cigarroa, J.E.; Grundy, S.M.; Cohen, J.C., 1999:
Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations

Park, K-Woo.; Choi, J-Ho.; Chae, I-Ho.; Cho, H-Jai.; Oh, S.; Kim, H-Soo.; Lee, M-Mook.; Park, Y.Bae.; Choi, Y-Shik., 2003:
Hepatic lipase C514T polymorphism and its relationship with plasma HDL-C levels and coronary artery disease in Koreans

Grundy, S.M.; Vega, G.L.; Otvos, J.D.; Rainwater, D.L.; Cohen, J.C., 1999:
Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men. Genetic and pharmacological evidence

Deeb, S.S.; Zambon, A.; Carr, M.C.; Ayyobi, A.F.; Brunzell, J.D., 2003:
Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet

Lambert, G.; Amar, M.J.; Martin, P.; Fruchart-Najib, J.; Föger, B.; Shamburek, R.D.; Brewer, H.B.; Santamarina-Fojo, S., 2000:
Hepatic lipase deficiency decreases the selective uptake of HDL-cholesteryl esters in vivo

Nong, Z.; Gonzalez-Navarro, H.; Amar, M.; Freeman, L.; Knapper, C.; Neufeld, E.B.; Paigen, B.J.; Hoyt, R.F.; Fruchart-Najib, J.; Santamarina-Fojo, S., 2003:
Hepatic lipase expression in macrophages contributes to atherosclerosis in apoE-deficient and LCAT-transgenic mice

Amar, M.J.; Dugi, K.A.; Haudenschild, C.C.; Shamburek, R.D.; Foger, B.; Chase, M.; Bensadoun, A.; Hoyt, R.F.; Brewer, H.B.; Santamarina-Fojo, S., 1998:
Hepatic lipase facilitates the selective uptake of cholesteryl esters from remnant lipoproteins in apoE-deficient mice

Fan, Y.M.; Laaksonen, R.; Janatuinen, T.; Vesalainen, R.; Nuutila, P.; Koivula, T.; Knuuti, J.; Lehtimaki, T., 2001:
Hepatic lipase gene variation is related to coronary reactivity in healthy young men

Brundert, M.; Heeren, J.; Greten, H.; Rinninger, F., 2003:
Hepatic lipase mediates an increase in selective uptake of HDL-associated cholesteryl esters by cells in culture independent from SR-BI

Rinninger, F.; Mann, W.A.exander; Kaiser, T.; Ahle, S.; Meyer, N.; Greten, H., 1998:
Hepatic lipase mediates an increase in selective uptake of high-density lipoprotein-associated cholesteryl esters by human Hep 3B hepatoma cells in culture

Chen, W.; Srinivasan, S.R.; Boerwinkle, E.; Berenson, G.S., 2003:
Hepatic lipase promoter C-514T polymorphism influences serial changes in HDL cholesterol levels since childhood: The Bogalusa Heart Study

Botma, G.J.n; Verhoeven, A.J.M.; Jansen, H., 2001:
Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor

Lambert, G.; Chase, M.B.; Dugi, K.; Bensadoun, A.; Brewer, H.B.; Santamarina-Fojo, S., 1999:
Hepatic lipase promotes the selective uptake of high density lipoprotein-cholesteryl esters via the scavenger receptor B1

Jansen, H.; Verhoeven, A.J.M.; Sijbrands, E.J.G., 2002:
Hepatic lipase: a pro- or anti-atherogenic protein?

Perret, B.; Mabile, L.; Martinez, L.; Tercé, Fçois.; Barbaras, R.; Collet, X., 2002:
Hepatic lipase: structure/function relationship, synthesis, and regulation

Mensenkamp, A.R.; Van Luyn, M.J.A.; Van Goor, H.; Bloks, V.; Apostel, F.; Greeve, J.; Hofker, M.H.; Jong, M.C.; Van Vlijmen, B.J.M.; Havekes, L.M.; Kuipers, F., 2000:
Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice

Niemela, O.; Parkkila, S.; Britton, R.S.; Brunt, E.; Janney, C.; Bacon, B., 1999:
Hepatic lipid peroxidation in hereditary hemochromatosis and alcoholic liver injury

Giordano, A.L.; Corrada, Y.; Arauz, S.; Pintos, M.E.; Tortora, C.M.; Gobello, C., 2003:
Hepatic lipidosis associated with malnutrition and pregnancy in two bitches

Cachefo, A.; Boucher, P.; Vidon, C.; Dusserre, E.; Diraison, F.; Beylot, M., 2001:
Hepatic lipogenesis and cholesterol synthesis in hyperthyroid patients

O'Sullivan, D.A.; Torres, V.E.; de Groen, P.C.; Batts, K.P.; King, B.F.; Vockley, J., 1998:
Hepatic lymphangiomatosis mimicking polycystic liver disease

Kahlenberg, M.S.; Kane, J.M.; Kanter, P.M.; Weber, T.K.; Gibbs, J.F.; Rodriguez-Bigas, M.A.; Petrelli, N.J., 2001:
Hepatic lymphatic mapping: a pilot study for porta hepatis lymph node identification

Yoshida, Y.; Kobayashi, E.; Nozawa, M.; Uchida, H.; Fujimura, A.; Yamanaka, T.; Miyata, M., 2000:
Hepatic lymphocyte transplantation in hyperbilirubinemic gunn rats

Burdan, F.; Siezieniewska, Z.; Maciejewski, R.; Madej, B.; Radzikowska, E.; Wojtowicz, Z., 2002:
Hepatic lysosomal enzymes activity and liver morphology after short-time omeprazole administration

Jacob, S.; Farr, G.; D.V.n, D.; Takiff, H.; Mason, A., 1999:
Hepatic manifestations of familial patent ductus venosus in adults

D.K.rguenec, C.; Hillaire, S.; Molinie, V.; Gardin, C.; Degott, C.; Erlinger, S.; Valla, D., 2001:
Hepatic manifestations of hemophagocytic syndrome: A study of 30 cases

Hamazaki, T.; IIboshi, Y.; Oka, M.; Papst, P.J.; Meacham, A.M.; Zon, L.I.; Terada, N., 2001:
Hepatic maturation in differentiating embryonic stem cells in vitro

Kitano, Y.; Ruchelli, E.; Weiner, S.; Adzick, N.S., 2000:
Hepatic mesenchymal hamartoma associated with mesenchymal stem villous hyperplasia of the placenta

Higashikawa, F.; Murakami, T.; Makino, M.; Takano, M., 1999:
Hepatic metabolic clearance of midazolam, a cytochrome P450 3A substrate, in the presence of ketoconazole in rats

Bort, R.; Mace, K.; Boobis, A.; Gomez Lechon, M.J.se; Pfeifer, A.; Castell, J., 1999:
Hepatic metabolism of diclofenac: Role of human CYP in the minor oxidative pathways

Carrera, G.; Paternain, J.L.is; Carrere, N.; Folch, J.; Courtade Saidi, M.; Orfila, C.; Vinel, J.P.erre; Alric, L.; Pipy, B., 2003:
Hepatic metallothionein in patients with chronic hepatitis C: Relationship with severity of liver disease and response to treatment

Dobrovoljc, K.; Falnoga, I.; Bulog, B.; Tusek-Znidaric, M.; Scancar, J., 2003:
Hepatic metallothioneins in two neotenic salamanders, Proteus anguinus and Necturus maculosus (Amphibia, Caudata)

Valls, C.; Andía, E.; Sánchez, A.; Gumà, A.; Figueras, J.; Torras, J.; Serrano, T., 2001:
Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CT

Bonetto, S.; Pagano, F.; Bianco, R.; Soldi, S.; Nebuloni, M.; Vago, L., 1999:
Hepatic metastases from medullary thyroid carcinoma appearing twelve years after the eradication of primitive tumor: Cytological and radiological aspects

Ibarrola de Andrés, C.; Castellano Megías, V.M.; Ballestin Carcavilla, C.; Alberti Masgrau, N.; Perez Barrios, A.; D.A.ustín, P.A., 2001:
Hepatic metastases from the spindle cell variant of medullary thyroid carcinoma: report of a case with diagnosis by fine needle aspiration biopsy

van Erkel, A.R.; Pijl, M.E.J.; van den Berg-Huysmans, A.A.; Wasser, M.N.J.M.; van de Velde, C.J.H.; Bloem, J.L., 2002:
Hepatic metastases in patients with colorectal cancer: relationship between size of metastases, standard of reference, and detection rates

Tateishi, U.; Hasegawa, T.; Muramatsu, Y.; Moriyama, N., 2003:
Hepatic metastases of soft tissue angiosarcoma: CT and MR imaging findings

Koda, Y.; Kan, Z.; Wallace, S.; Kaminou, T.; Nakamura, K.; Yamada, R., 1999:
Hepatic microcirculatory changes induced by hepatic artery embolization in rats: original investigation

Hao, J.; Shi, J.; Ren, W.; Han, G.; Zhu, J.; Wang, S.; Xie, Y., 2002:
Hepatic microcirculatory disturbances in patients with chronic hepatitis B

Braun, K.M.; Thompson, A.W.; Sandgren, E.P., 2003:
Hepatic microenvironment affects oval cell localization in albumin-urokinase-type plasminogen activator transgenic mice

Arcand-Hoy, L., D.; Metcalfe, C., D., 2000:
Hepatic micronuclei in brown bullheads (Ameiurus nebulosus) as a biomarker for exposure to genotoxic chemicals

Chiba, I.; Sakakibara, A.; Iwata, H.; Ishizuka, M.; Tanabe, S.; Akahori, F.; Kazusaka, A.; Fujita, S., 2002:
Hepatic microsomal cytochrome P450s and chlorinated hydrocarbons in largha and ribbon seals from Hokkaido, Japan: Differential response of seal species to Ah receptor agonist exposure

Straus, D.L.; Schlenk, D.; Chambers, J.E., 2000:
Hepatic microsomal desulfuration and dearylation of chlorpyrifos and parathion in fingerling channel catfish: Lack of effect from Aroclor 1254

Stupans, I.; Kong, S.; Kirlich, A.; Murray, M.; Bailey, E.L.; Jones, B.R.; McKinnon, R.A., 1999:
Hepatic microsomal enzyme activity in the koala and tammar wallaby: high 17beta-hydroxysteroid oxidoreductase activity in koala liver microsomes

Horie, Y.; Kato, S.; Ohki, E.; Tamai, H.; Yamagishi, Y.; Ishii, H., 2000:
Hepatic microvascular dysfunction in endotoxemic rats after acute ethanol administration

Onori, P.; Morini, S.; Franchitto, A.; Sferra, R.; Alvaro, D.; Gaudio, E., 2000:
Hepatic microvascular features in experimental cirrhosis: A structural and morphometrical study in CCl4-treated rats

Mori, N.; Horie, Y.; Nimura, Y.; Wolf, R.; Granger, D.N., 2000:
Hepatic microvascular responses to ischemia-reperfusion in low-density lipoprotein receptor knockout mice

Okatani, Yuji; Wakatsuki, Akihiko; Reiter, Russel, J.; Miyahara, Yasuyo, 2002:
Hepatic mitochondrial dysfunction in senescence-accelerated mice: Correction by long-term, orally administered physiological levels of melatonin

Kanbagli, O.; Balkan, J.; Aykaç-Toker, Gülçin.; Uysal, Müjdat., 2002:
Hepatic mitochondrial prooxidant and antioxidant status in ethanol-induced liver injury in rats

Benzerrouk, R.; Qureshi, I.A., 2001:
Hepatic mitochondrial proteins in congenitally hyperammonemic spf mice: effect of acetyl-L-carnitine

Ito, K.; Mitchell, D.G., 2000:
Hepatic morphologic changes in cirrhosis: MR imaging findings

Vermijlen, D.; Luo, D.; Froelich, C.J.; Medema, J.Paul.; Kummer, J.Alain.; Willems, E.; Braet, F.; Wisse, E., 2002:
Hepatic natural killer cells exclusively kill splenic/blood natural killer-resistant tumor cells by the perforin/granzyme pathway

Kawakami, S.; Arima, T.; Harada, K.; Miyazono, H.; Oketani, M.; Miyazaki, H.; Arima, T., 2001:
Hepatic necrosis with cholestasis induced by long-term voglibose administration

Vilgrain, V.; Lewin, M.; Vons, C.; Denys, A.; Valla, D.; Flejou, J.F.; Belghiti, J.; Menu, Y., 1999:
Hepatic nodules in Budd-Chiari syndrome: imaging features

Takayasu, K.; Muramatsu, Y.; Wakao, F.; Mizuguchi, Y.; Iwata, R.; Maeda, T.; Moriyama, N.; Sakamoto, M., 2002:
Hepatic nodules with early enhancement during computed tomography portography: Report of six cases

Schneiter, P.; Gillet, M.; Chiolero, R.; Jequier, E.; Tappy, L., 1999:
Hepatic nonoxidative disposal of an oral glucose meal in patients with liver cirrhosis

Párrizas, M.; Maestro, M.A.; Boj, S.F.; Paniagua, A.; Casamitjana, R.; Gomis, R.; Rivera, F.; Ferrer, J., 2001:
Hepatic nuclear factor 1-alpha directs nucleosomal hyperacetylation to its tissue-specific transcriptional targets

Gauthier, B.R.; Schwitzgebel, V.M.; Zaiko, M.; Mamin, A.; Ritz-Laser, B.; Philippe, J., 2002:
Hepatic nuclear factor-3 (HNF-3 or Foxa2) regulates glucagon gene transcription by binding to the G1 and G2 promoter elements

van der Merwe, S.W.; van den Bogaerde, J.B.; Goosen, C.; Maree, F.F.; Milner, R.J.; Schnitzler, C.M.; Biscardi, A.; Mesquita, J.M.; Engelbrecht, G.; Kahn, D.; Fevery, J., 2003:
Hepatic osteodystrophy in rats results mainly from portasystemic shunting

van der Merwe, S.W.; Attfield, D.; Fevery, J.; Bogaerde, J.B., 2000:
Hepatic osteodystrophy: the influence of liver disease and portal hypertension on cytokine activation

Shimano, K.; Satake, M.; Okaya, A.; Kitanaka, J.; Kitanaka, N.; Takemura, M.; Sakagami, M.; Terada, N.; Tsujimura, T., 2003:
Hepatic oval cells have the side population phenotype defined by expression of ATP-binding cassette transporter ABCG2/BCRP1

Rahimian, R.; Masih-Khan, E.; Lo, M.; van Breemen, C.; McManus, B.M.; Dubé, G.P., 2001:
Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus

Vendemiale, G.; Grattagliano, I.; Lupo, L.; Memeo, V.; Altomare, E., 2002:
Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect of surgical drainage

Arrieta Acevedo, J.M.uro; Diaz Cruz, A.; Avila Gonzalez, E.; Guinzberg Perrusquia, R.; Pina Garza, E., 2000:
Hepatic oxidative status and performance in broiler chicks fed with two sources of selenium and high levels of vitamins E and C

Guzman, R.E.; Solter, P.F., 1999:
Hepatic oxidative stress following prolonged sublethal microcystin LR exposure

Hashimoto, M.; Watanabe, G., 2000:
Hepatic parenchymal cell volume and the indocyanine green tolerance test

Sheafor, D.H.; Killius, J.S.; Paulson, E.K.; DeLong, D.M.; Foti, A.M.; Nelson, R.C., 2000:
Hepatic parenchymal enhancement during triple-phase helical CT: can it be used to predict which patients with breast cancer will develop hepatic metastases?

Fujita, T.; Ito, K.; Honjo, K.; Okazaki, H.; Matsumoto, T.; Matsunaga, N., 2002:
Hepatic parenchymal enhancement in the cirrhotic liver: Evaluation by triple-phase dynamic MRI

Taniai, N.; Onda, M.; Tajiri, T.; Akimaru, K.; Yoshida, H.; Mamada, Y., 2002:
Hepatic parenchymal resection using an ultrasonic surgical aspirator with electrosurgical coagulation

Arita, T.; Matsunaga, N.; Takano, K.; Hara, A.; Fujita, T.; Honjo, K., 1999:
Hepatic perfusion abnormalities in acute pancreatitis: CT appearance and clinical importance

Koranda, P.; Myslivecek, M.; Erban, J.; Seidlová, V.; Husák, V., 1999:
Hepatic perfusion changes in patients with cirrhosis indices of hepatic arterial blood flow

Motoo, Y.; Yamaguchi, Y.; Watanabe, H.; Okai, T.; Sawabu, N., 2001:
Hepatic peribiliary cysts diagnosed by magnetic resonance cholangiography

Zissin, R.; Kots, E.; Rachmani, R.; Hadari, R.; Shapiro Feinberg, M., 2000:
Hepatic periportal tracking associated with severe acute pyelonephritis

Kerckaert, I.; Poll The, B.T.; Espeel, M.; Duran, M.; Roeleveld, A.B.C.; Wanders, R.J.A.; Roels, F., 2000:
Hepatic peroxisomes in isolated hyperpipecolic acidaemia: Evidence supporting its classification as a single peroxisomal enzyme deficiency

Strubbe, J.H.; Bruggink, J.E.; Steffens, A.B., 1999:
Hepatic portal vein cannulation for infusion and blood sampling in freely moving rats

Niki, M.; Shimizu, I.; Horie, T.; Okazaki, M.; Shiraishi, T.; Takeuchi, H.; Fujiwara, S.; Murata, M.; Yamamoto, K.; Iuchi, A.; Atagi, Y.; Ito, S., 2002:
Hepatic portal venous gas disappearing within 24 hours

Nguyen, H.N.; Purucker, E.; Riehl, J.; Matern, S., 1998:
Hepatic portal venous gas following emergency endoscopic sclerotherapy of gastric varices

Net, M.; Valero, R.; Almenara, R.; Deulofeu, R.; López-Boado, M.A.; Capdevila, L.; Barros, P.; Bombí, J.A.; Agustí, Mè.; Adalia, R.; Ruiz, A.; Arce, Y.; Manyalich, Mí.; García-Valdecasas, J.C., 2003:
Hepatic preconditioning after prolonged warm ischemia by means of S-adenosyl-L-methionine administration in pig liver transplantation from non-heart-beating donors

Peralta, C.; Bartrons, R.; Riera, L.; Manzano, A.; Xaus, C.; Gelpí, E.; Roselló-Catafau, J., 2000:
Hepatic preconditioning preserves energy metabolism during sustained ischemia

Neveux, N.; D.B.ndt, J.P.; Chaumeil, J.C.; Cynober, L., 2002:
Hepatic preservation, liposomally entrapped adenosine triphosphate and nitric oxide production: A study of energy state and protein metabolism in the cold-stored rat liver

Chatziioannou, A.N.; Metafa, A.; Mourikis, D.; Katsenis, K.; Gouliamos, A.; Smyrniotis, V.; Koutoulidis, V.; Prahalias, A.; Kavatzas, N.; Vlachos, L., 2002:
Hepatic primary and secondary malignancies: comparison of helical CT and helical CT during arterial portography

Ferre, N.; Girona, J.; Cabre, M.; Joven, J.; Laville, A.; Masana, L.; Paternain, J.L.is; Camps, J., 1999:
Hepatic production of apolar aldehydes in rats with carbon tetrachloride-induced cirrhosis

Zhang, M.; Sell, S.; Leffert, H.L., 2003:
Hepatic progenitor cell lines from allyl alcohol-treated adult rats are derived from gamma-irradiated mouse STO cells

Libbrecht, L.; D.V.s, R.; Cassiman, D.; Desmet, V.; Aerts, R.; Roskams, T., 2001:
Hepatic progenitor cells in hepatocellular adenomas

Edvardsson, U.; von Löwenhielm, H.Brockenhuus.; Panfilov, O.; Nyström, A-Christin.; Nilsson, F.; Dahllöf, Börn., 2003:
Hepatic protein expression of lean mice and obese diabetic mice treated with peroxisome proliferator-activated receptor activators

Le Couteur, D.G.; Fraser, R.; Cogger, V.C.; McLean, A.J., 2002:
Hepatic pseudocapillarisation and atherosclerosis in ageing

Alsolaiman, M.M.; MacDermott, R.P.; Bartholomew, C., 2002:
Hepatic pseudocyst as the first presentation of squamous cell carcinoma of uterine cervix

Behl, R.; Deodhar, A.D., 1999:
Hepatic pyridine nucleotides content in rat-A better indicator for determining available niacin valves of food

Austin, T.W.; Lagasse, E., 2003:
Hepatic regeneration from hematopoietic stem cells

Liu, Y.Y.; Rajkumar, K.; Murphy, L.J., 1999 :
Hepatic regeneration in insulin-like growth factor binding protein-1 transgenic mice

Fulop, A.K.; Pocsik, E.; Brozik, M.; Karabelyos, C.; Kiss, A.; Novak, I.; Szalai, C.; Dobozy, O.; Falus, A., 2001:
Hepatic regeneration induces transient acute phase reaction: systemic elevation of acute phase reactants and soluble cytokine receptors

Svetlov, S.I.; Sturm, E.; Olson, M.S.; Crawford, J.M., 1999:
Hepatic regulation of platelet-activating factor acetylhydrolase and lecithin: Cholesterol acyltransferase biliary and plasma output in rats exposed to bacterial lipopolysaccharide

Belli, G.; Iannelli, A.; Romano, G.; Marano, I., 1999:
Hepatic resection and percutaneous ethanol injection for the treatment of selected patients with more than one hepatocellular carcinoma

Chen, Miin Fu, 2000:
Hepatic resection for benign tumours of the liver

Liu, C.L.; Fan, S.T.; Lo, C.M.; Law, W.L.; Ng, I.O.L.; Wong, J., 2002:
Hepatic resection for colorectal liver metastases: prospective study

Teh, C.S.C.; Ooi, L.L.P.J., 2003:
Hepatic resection for colorectal metastases to the liver: The National Cancer Centre/Singapore General Hospital experience

Ezaki, T.; Yamamoto, K.; Yamaguchi, H.; Sasaki, Y.; Ishida, T.; Mori, M.; Aimitsu, S., 2002:
Hepatic resection for hepatocellular carcinoma existing with liver cirrhosis

Hanazaki, K.; Kajikawa, S.; Shimozawa, N.; Shimada, K.; Hiraguri, M.; Koide, N.; Adachi, W.; Amano, J., 2002:
Hepatic resection for hepatocellular carcinoma in diameter of gtoreq10cm

Kaibori, M.; Matsui, Y.; Kitade, H.; Kwon, A-Hon.; Kamiyama, Y., 2003 :
Hepatic resection for hepatocellular carcinoma in severely cirrhotic livers

Itamoto, T.; Asahara, T.; Katayama, K.; Nakahara, H.; Fukuda, T.; Yano, M.; Hino, H.; Nakahara, M.; Dohi, K.; Shimamoto, F., 2001:
Hepatic resection for intrahepatic cholangiocarcinoma: relation to gross tumor morphology

Idani, H.; Narusue, M.; Kin, H.; Uda, K.; Muro, M.; Kaneko, A.; Sasaki, H.; Watanabe, K.; Takahashi, K., 2001:
Hepatic resection for liver metastasis of sigmoid colon cancer after incomplete percutaneous microwave coagulation therapy

Merideth, M.A.; Cliby, W.A.; Keeney, G.L.; Lesnick, T.G.; Nagorney, D.M.; Podratz, K.C., 2003:
Hepatic resection for metachronous metastases from ovarian carcinoma

Jourdan, J.L.; Cannan, R.; Stubbs, R., 1999:
Hepatic resection for metastases in colorectal carcinoma

Takada, Y.; Otsuka, M.; Seino, K.; Taniguchi, H.; Koike, N.; Kawamoto, T.; Koda, K.; Adachi, S.; Yuzawa, K.; Nozue, M.; Todoroki, T.; Fukao, K., 2001:
Hepatic resection for metastatic tumors from noncolorectal carcinoma

Lee, J.Hoon.; Kim, K.Sik.; Chung, C.Woon.; Park, Y.Nyun.; Kim, B.Ro., 2002:
Hepatic resection of metastatic tumor from serous cystadenocarcinoma of the ovary

Kaiho, T.; Tanaka, T.; Tsuchiya, S.; Yanagisawa, S.; Takeuchi, O.; Miura, M.; Saigusa, N.; Kitakata, Y.; Miyazaki, M., 2003:
Hepatic resection under in situ hypothermic hepatic perfusion

Ezaki, T.; Yamaguchi, H.; Sasaki, Y.; Ishida, T.; Fujiwara, M., 2001:
Hepatic resection under selective portal vein occlusion using degradable starch microspheres. A simple procedure of an experimental study using the pig

Ochiai, T.; Takayama, T.; Inoue, K.; Yamamoto, J.; Shimada, K.; Kosuge, T.; Yamazaki, S.; Makuuchi, M., 1999:
Hepatic resection with and without surgical margins for hepatocellular carcinoma in patients with impaired liver function

Asahara, T.; Itamoto, T.; Katayama, K.; Nakahara, H.; Hino, H.; Yano, M.; Ono, E.; Dohi, K.; Nakanishi, T.; Kitamoto, M.; Azuma, K.; Itoh, K.; Shimamoto, F., 1999:
Hepatic resection with tumor thrombectomy for hepatocellular carcinoma with tumor thrombi in the major vasculatures

Buell, J.F.; Rosen, S.; Yoshida, A.; Labow, D.; Limsrichamrern, S.; Cronin, D.C.; Bruce, D.S.; Wen, M.; Michelassi, F.; Millis, J.M.; Posner, M.C., 2000:
Hepatic resection: effective treatment for primary and secondary tumors

Hamy, A.P.; Paineau, J.R.; Mirallie, E.C.; Bizouarn, P.; Visset, J.P., 2000:
Hepatic resections for non-colorectal metastases: forty resections in 35 patients

Kim, W.R.; Wiesner, R.H.; Poterucha, J.J.; Therneau, T.M.; Malinchoc, M.; Benson, J.T.; Crippin, J.S.; Klintmalm, G.B.; Rakela, J.; Starzl, T.E.; Krom, R.A.; Evans, R.W.; Dickson, E.R., 1999:
Hepatic retransplantation in cholestatic liver disease: impact of the interval to retransplantation on survival and resource utilization

Yamada, S.; Mine, S.; Fujisaki, T.; Ohnari, N.; Eto, S.; Tanaka, Y., 2002:
Hepatic sarcoidosis associated with chronic hepatitis C

Malerød, L.; Sporstøl, M.; Juvet, L.K.; Mousavi, A.; Gjøen, T.; Berg, T., 2003:
Hepatic scavenger receptor class B, type I is stimulated by peroxisome proliferator-activated receptor gamma and hepatocyte nuclear factor 4alpha

Hayes, J.H.; Soroka, C.J.; Rios-Velez, L.; Boyer, J.L., 1999:
Hepatic sequestration and modulation of the canalicular transport of the organic cation, daunorubicin, in the Rat

Lerut, J.P.; Claeys, N.; Laterre, P.F.; Lavenne-Pardonge, E.; Ciccarelli, O.; Cavallaro, S.; Palazzo, U.; Renda, D.; Rigano, P.; Maggio, A., 1999:
Hepatic sickling: an unusual cause of liver allograft dysfunction

Tan, M.; D.C.rlo, A.; Liu, S.Qing.; Tector, A.Joseph.; Tchervenkov, J.I.; Metrakos, P., 2002:
Hepatic sinusoidal endothelium upregulates IL-1alpha, IFN-gamma, and iNOS in response to discordant xenogeneic islets in an in vitro model of xenoislet transplantation

Rajvanshi, P.; Shulman, H.M.; Sievers, E.L.; McDonald, G.B., 2002:
Hepatic sinusoidal obstruction after gemtuzumab ozogamicin (Mylotarg) therapy

Slehria, S.; Rajvanshi, P.; Ito, Y.; Sokhi, R.P.; Bhargava, K.K.; Palestro, C.J.; McCuskey, R.S.; Gupta, S., 2002:
Hepatic sinusoidal vasodilators improve transplanted cell engraftment and ameliorate microcirculatory perturbations in the liver

Lahlou, M.K.; Mansouri, F.; Gharib, N.; Benamer, S.; Essadel, E.; Mohammadine, E.; Taghy, A.; Chad, B.; Zizi, A.; Belmahi, A., 1999:
Hepatic space-occupying lesions due to tuberculosis. A review of five cases

Bleeker Rovers, C.P.; Kadir, S.W.; Van Leusen, R.; Richter, C., 2000:
Hepatic steatosis and lactic acidosis caused by stavudine in an HIV-infected patient

Hwang, S.J.ng; Luo, J.C.yuan; Chu, C.W.i; Lai, C.R.; Lu, C.L.ang; Tsay, S.H.w; Wu, J.C.ing; Chang, F.Y.ung; Lee, S.D.ng, 2001:
Hepatic steatosis in chronic hepatitis C virus infection: Prevalence and clinical correlation

Ohata, K.; Hamasaki, K.; Toriyama, K.; Matsumoto, K.; Saeki, A.; Yanagi, K.; Abiru, S.; Nakagawa, Y.; Shigeno, M.; Miyazoe, S.; Ichikawa, T.; Ishikawa, H.; Nakao, K.; Eguchi, K., 2003:
Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection

Albisetti, M.; Braegger, C.P.; Stallmach, T.; Willi, U.V.; Nadal, D., 1999:
Hepatic steatosis: A frequent non-specific finding in HIV-infected children

Baroni, G.S.; Pastorelli, A.; Manzin, A.; Benedetti, A.; Marucci, L.; Solforosi, L.; D.S.rio, A.; Brunelli, E.; Orlandi, F.; Clementi, M.; Macarri, G., 1999:
Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C

Washington, K.; Wright, K.; Shyr, Y.; Hunter, E.B.; Olson, S.; Raiford, D.S., 2000:
Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver

da Silva, F.M.; Guimarães, E.L.M.; Grivicich, I.; Trindade, V.Maria.T.; Guaragna, R.Maria.; Borojevic, R.; Guma, Fátima.C.R., 2003:
Hepatic stellate cell activation in vitro: cell cycle arrest at G2/M and modification of cell motility

Cassiman, D.; Libbrecht, L.; Desmet, V.; Denef, C.; Roskams, T., 2002:
Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers

Sato, Y.; Asada, Y.; Hara, S.; Marutsuka, K.; Tamura, K.; Hayashi, T.; Sumiyoshi, A., 1999:
Hepatic stellate cells (Ito cells) in veno-occlusive disease of the liver after allogeneic bone marrow transplantation

Tsukamoto, Hide, 2002:
Hepatic stellate cells as a target for TZD: Can we treat liver fibrosis and type II diabetes at the same time?

Zhou, Y.; Shimizu, I.; Lu, G.; Itonaga, M.; Okamura, Y.; Shono, M.; Honda, H.; Inoue, S.; Muramatsu, M.; Ito, S., 2001:
Hepatic stellate cells contain the functional estrogen receptor beta but not the estrogen receptor alpha in male and female rats

Ogi, M.; Yokomori, H.; Inao, M.; Oda, M.; Ishii, H., 2000:
Hepatic stellate cells express Ca2+ pump-ATPase and Ca2+-Mg2+-ATPase in plasma membrane of caveolae

Trim, N.; Morgan, S.; Evans, M.; Issa, R.; Fine, D.; Afford, S.; Wilkins, B.; Iredale, J., 2000:
Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation

Wu, J.; Zern, M.A., 2000:
Hepatic stellate cells: A target for the treatment of liver fibrosis

Reynaert, H.; Thompson, M.G.; Thomas, T.; Geerts, A., 2002:
Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension

Sato, M.; Suzuki, S.; Senoo, H., 2003:
Hepatic stellate cells: unique characteristics in cell biology and phenotype

Vessey, C.J.; de la Hall, P.M., 2001:
Hepatic stem cells: a review

Mitaka, T., 2001:
Hepatic stem cells: from bone marrow cells to hepatocytes

Margeli, A.P.; Manolis, E.; Skaltsas, S.N.; Tsarpalis, K.S.; Mykoniatis, M.G.; Theocharis, S.E., 2002:
Hepatic stimulator substance activity in animal model of fulminant hepatic failure and encephalopathy

Margeli, A.P.; Skaltsas, S.D.; Spiliopoulou, C.A.; Mykoniatis, M.G.; Theocharis, S.E., 1999:
Hepatic stimulator substance activity in the liver of thioacetamide-intoxicated rats

Margeli, A.P.; Papadimitriou, L.; Ninos, S.; Manolis, E.; Mykoniatis, M.G.; Theocharis, S.E., 2003:
Hepatic stimulator substance administration ameliorates liver regeneration in an animal model of fulminant hepatic failure and encephalopathy

Smith, W.E.; Kahler, S.G.; Frush, D.P.; Milov, D.E.; Gottfried, M.R.; Chen, Y.T., 2001:
Hepatic storage of glycogen in Niemann-Pick disease type B

Hirata, N.; Kushida, Y.; Ohguri, T.; Wakasugi, S.; Kojima, T.; Fujita, R., 1999:
Hepatic subcapsular hematoma after extracorporeal shock wave lithotripsy (ESWL) for pancreatic stones

Leij-Halfwerk, S.; Dagnelie, P.C.; Van Den Berg, J.W.; Wilson, J.H.; Sijens, P.E., 2000:
Hepatic sugar phosphate levels reflect gluconeogenesis in lung cancer: simultaneous turnover measurements and 31P magnetic resonance spectroscopy in vivo

Gaetani, S.; Bellovino, D.; Apreda, M.; Devirgiliis, C., 2003:
Hepatic synthesis, maturation and complex formation between retinol-binding protein and transthyretin

Itoh, S.; Onishi, S., 2000:
Hepatic taurine, glycine and individual bile acids in early human fetus

Arora, N.K.; Kohli, R.; Gupta, D.K.; Bal, C.S.; Gupta, A.K.; Gupta, S.D., 2001:
Hepatic technetium-99m-mebrofenin iminodiacetate scans and serum gamma-glutamyl transpeptidase levels interpreted in series to differentiate between extrahepatic biliary atresia and neonatal hepatitis

Alam, I.; Bass, N.M.; Bacchetti, P.; Gee, L.; Rockey, D.C., 2000:
Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites

Runnegar, M.; Seward, D.J.; Ballatori, N.; Crawford, J.M.; Boyer, J.L., 1999:
Hepatic toxicity and persistence of ser/thr protein phosphatase inhibition by microcystin in the little skate Raja erinacea

Baker, D.G.; Taylor, H.W.; Lee, S.P.; Barker, S.A.; Goad, M.E.; Means, J.C., 2001:
Hepatic toxicity and recovery of Fischer 344 rats following exposure to 2-aminoanthracene by intraperitoneal injection

Bink, H.; Carbó, N.; Felipe, A.; López-Soriano, F.J.; Argilés, J.M., 2001:
Hepatic transport of gluconeogenic substrates during tumor growth in the rat

Ferenci, P.; Zollner, G.; Trauner, M., 2002:
Hepatic transport systems

Medh, J.D.; Bowen, S.L.; Fry, G.L.; Ruben, S.; Hill, J.; Wong, H.; Chappell, D.A., 1999:
Hepatic triglyceride lipase promotes low density lipoprotein receptor-mediated catabolism of very low density lipoproteins in vitro

Li-Qiang; Hao-Xishan; Sun-Tao, 2000:
Hepatic trisegmentectomy for huge liver cancer (report of 10 cases)

Forsberg, F.; Piccoli, C.W.; Liu, J-Bin.; Rawool, N.M.; Merton, D.A.; Mitchell, D.G.; Goldberg, B.B., 2002:
Hepatic tumor detection: MR imaging and conventional US versus pulse-inversion harmonic US of NC100100 during its reticuloendothelial system-specific phase

Bezy Wendling, J.; Kretowski, M.; Rolland, Y., 2003:
Hepatic tumor enhancement in computed tomography: Combined models of liver perfusion and dynamic imaging

Hafeli, U., O.; Casillas, S.; Dietz, D., W.; Pauer, G., J.; Rybicki, L., A.; Conzone, S., D.; Day, D., E., 1999:
Hepatic tumor radioembolization in a rat model using radioactive rhenium (186RE/188RE) glass microspheres

Tsutani, H.; Inai, K.; Kishi, S.; Morinaga, K.; Naiki, H.; Ueda, T., 1999:
Hepatic tumor rupture following effectual treatment with irinotecan in a patient with highly refractory malignant lymphoma

Syasina, I.G.; Sokolovsky, A.S., 2001:
Hepatic tumors in flatfish from Sivuchya Bight (Peter the Great Bay, Sea of Japan)

Dromain, C.; D.B.ere, T.; Elias, D.; Kuoch, V.; Ducreux, M.; Boige, V.; Petrow, P.; Roche, A.; Sigal, R., 2002:
Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up

Kim, T.K.; Choi, B.I.; Han, J.K.; Hong, H.S.; Park, S.H.; Moon, S.G., 2000:
Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US

Blessmann, J.; L.V.n, A.; Tannich, E., 2003:
Hepatic ultrasound in a population with high incidence of invasive amoebiasis: evidence for subclinical, self-limited amoebic liver abscesses

Fan, F.; Tawfik, O.; Bhatia, P.; Lee, K.-Rak; Forster, J., 1998:
Hepatic undifferentiated (embryonal) sarcoma: A case report with fine needle aspiration cytology and histology

Kobayashi, N.; Kuramoto, T.; Yamaoka, K.; Hashida, M.; Takakura, Y., 2001:
Hepatic uptake and gene expression mechanisms following intravenous administration of plasmid DNA by conventional and hydrodynamics-based procedures

Cui, Y.; König, J.; Leier, I.; Buchholz, U.; Keppler, D., 2001:
Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6

Ismair, M.G.; Stieger, B.; Cattori, V.; Hagenbuch, B.; Fried, M.; Meier, P.J.; Kullak Ublick, G.A., 2001:
Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting polypeptides Oatp4 and OATP8 of rat and human liver

Persico, M.; Persico, E.; Bakker, C.T.; Rigato, I.; Amoroso, A.; Torella, R.; Bosma, P.J.; Tiribelli, C.; Ostrow, J.D., 2001:
Hepatic uptake of organic anions affects the plasma bilirubin level in subjects with Gilbert's syndrome mutations in UGT1A1

Ogawara, K.I.hi; Yoshida, M.; Higaki, K.; Kimura, T.; Shiraishi, K.; Nishikawa, M.; Takakura, Y.; Hashida, M., 1999:
Hepatic uptake of polystyrene microspheres in rats: Effect of particle size on intrahepatic distribution

So, P.W.; Fuller, B.J., 2001 :
Hepatic uptake of solutes from the preservation solution during hypothermic storage: a (1)H NMR study in rat liver

van Montfoort, J.E.; Stieger, B.; Meijer, D.K.; Weinmann, H.J.; Meier, P.J.; Fattinger, K.E., 1999:
Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1

Phositlimpagul, A.; Edwards, G.L.; Azain, M.J., 2002:
Hepatic vagotomy disrupts somatotropin-induced protein selection

Wax, J.R.; Blackstone, J.; Pinette, M.G.; Cartin, A., 2001:
Hepatic vascular calcification: an early second trimester sonographic feature of idiopathic infantile arterial calcinosis

Alexander, H.Richard.; Libutti, S.K.; Bartlett, D.L.; Pingpank, J.F.; Kranda, K.; Helsabeck, C.; Beresnev, T., 2002:
Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapy

Yokoyama, Yukihiro; Alterman, Daniel, M.; Sarmadi, Amir, H.; Baveja, Rajiv; Zhang, Jian, X.; Huynh, Toan; Clemens, Mark, G., 2002:
Hepatic vascular response to elevated intraperitoneal pressure in the rat

Ikeda, K.; Saitoh, S.; Kobayashi, M.; Suzuki, Y.; Suzuki, F.; Tsubota, A.; Arase, Y.; Chayama, K.; Murashima, N.; Kumada, H., 2000:
Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma

Ohwada, S.; Takeyoshi, I.; Ogawa, T.; Ohya, T.; Saitoh, A.; Kawashima, K.; Iino, Y.; Morishita, Y., 1998:
Hepatic vein reconstruction at inferior vena cava confluence using left renal vein graft

Noujaim, H.M.; Mirza, D.F.; Mayer, D.A.; D.V.lle D.G.yet, J., 2002:
Hepatic vein reconstruction in ex situ split-liver transplantation

Baskett, R.J.F.; Ross, D.B.; Warren, A.E.; Sharratt, G.P.; Murphy, D.A., 1999:
Hepatic vein to the azygous vein anastomosis for pulmonary arteriovenous fistulae

Sayer, H.G.; Will, U.; Schilling, K.; Vogt, T.; Wollina, K.; Höffken, K., 2002:
Hepatic veno-occlusive disease (VOD) with complete occlusion of liver venules after tandem autologous stem cell transplantation-- successful treatment with high-dose methylprednisolone and defibrotide

Zuckerman, M.; Steenkamp, V.; Stewart, M.J., 2002:
Hepatic veno-occlusive disease as a result of a traditional remedy: confirmation of toxic pyrrolizidine alkaloids as the cause, using an in vitro technique

Richardson, P.; Guinan, E., 2001:
Hepatic veno-occlusive disease following hematopoietic stem cell transplantation

Ishida, Y.; Utikoshi, M.; Kurosaki, M.; Ohta, K.; Chujo, T.; Aoyama, S.; Ohsawa, K.; Saito, K.; Yokoyama, H.; Ohta, S., 1998:
Hepatic veno-occlusive disease in a case of polymyositis associated with thrombotic thrombocytopenic purpura/hemolytic uremic syndrome

Srisirirojanakorn, N.; Finegold, M.J.; Gopalakrishna, G.S.; Klish, W.J., 1999:
Hepatic veno-occlusive disease in ataxia-telangiectasia

Neumeister, P.; Eibl, M.; Zinke-Cerwenka, W.; Scarpatetti, M.; Sill, H.; Linkesch, W., 2001:
Hepatic veno-occlusive disease in two patients with relapsed acute myeloid leukemia treated with anti-CD33 calicheamicin (CMA-676) immunoconjugate

Mortelé, K.J.; Van Vlierberghe, H.; Wiesner, W.; Ros, P.R., 2002:
Hepatic veno-occlusive disease: MRI findings

Kishi, M.; Maeyama, S.; Ogata, S.; Koike, J.; Uchikoshi, T., 1999:
Hepatic veno-occlusive lesions in severe alcoholic hepatitis and alcoholic liver cirrhosis: A comparative histopathological study in autopsy cases

Lo, C-Mau.; Fan, S-Tat.; Liu, C-Leung.; Wong, J., 2003:
Hepatic venoplasty in living-donor liver transplantation using right lobe graft with middle hepatic vein

Hicken, B.L.; Sharara, A.I.; Abrams, G.A.; Eloubeidi, M.; Fallon, M.B.; Arguedas, M.R., 2003:
Hepatic venous pressure gradient measurements to assess response to primary prophylaxis in patients with cirrhosis: A decision analytical study

Sugimoto, K-Ichi.; Ohmori, M.; Fujimura, A.; Sakamoto, K-ichi.; Sudoh, T.; Yamauchi, H.; Mizuta, K.; Hishikawa, S.; Kitamura, T.; Kawarasaki, H., 2003:
Hepatic venous stenosis-related reduction of cyclosporin clearance in a pediatric patient after liver transplantation

Grosell, M.; O'Donnell, M.J.; Wood, C.M., 2000:
Hepatic versus gallbladder bile composition: in vivo transport physiology of the gallbladder in rainbow trout

Taghibiglou, C.; Rashid-Kolvear, F.; Van Iderstine, S.C.; Le-Tien, H.; Fantus, I.George.; Lewis, G.F.; Adeli, K., 2001:
Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance

Fletcher, N.; Hanberg, A.; Håkansson, H., 2001:
Hepatic vitamin a depletion is a sensitive marker of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in four rodent species

Hoshida, Y.; Shiratori, Y.; Koike, Y.; Obi, S.; Hamamura, K.; Teratani, T.; Shiina, S.; Omata, M., 2002:
Hepatic volumetry to predict adverse events in percutaneous ablation of hepatocellular carcinoma

Net, M.; Valero, R.; Almenara, R.; Rull, R.; Gonzalez, F.J.; Taurá, P.; Lopez-Boado, M.A.; Deulofeu, R.; Elena, M.; Capdevila, L.; Cabrer, C.; Visa, J.; García-Valdecasas, J.C., 2001:
Hepatic xanthine levels as viability predictor of livers procured from non-heart-beating donor pigs

Norris, R.L.G.; Seawright, A.A.; Shaw, G.R.; Senogles, P.; Eaglesham, G.K.; Smith, M.J.; Chiswell, R.K.; Moore, M.R., 2002:
Hepatic xenobiotic metabolism of cylindrospermopsin in vivo in the mouse

Tamano, H.; Igasaki, E.; Enomoto, S.; Oku, N.; Itoh, N.; Kimura, T.; Tanaka, K.; Takeda, A., 2000:
Hepatic zinc response via metallothionein induction after tumor transplantation

Romero, J.R.; Fresnedo, O.; Isusi, E.; Barrionuevo, J.; Ochoa, B., 1999:
Hepatic zonation of the formation and hydrolysis of cholesteryl esters in periportal and perivenous parenchymal cells

Furuki, Tatsuwo, 1998:
Hepaticae and Anthoceroate of the the Goto Island, Southwestern Japan

Furuki, T.; Higuchi, M.; Nishimura, N., 2001:
Hepaticae and Anthocerotae of the Mikura Island, Izu Islands, northern Izu-Mariana Arch

Furuki, Tatsuwo, 2000:
Hepaticae of Mt. Ishizuchi, Shikoku, Southern Japan

Hedderson, T.A.; Soderstrom, L.; Brassard, G.R., 2001:
Hepaticae of the Torngat Mountains, northern Labrador, Canada

Nagino, M.; Kamiya, J.; Kanai, M.; Uesaka, K.; Sano, T.; Arai, T.; Nimura, Y., 2002:
Hepaticojejunostomy using a Roux-en-Y jejunal limb via the retrocolic-retrogastric route

Bratucu, E.; Ulmeanu, D.; Bota, D., 1998:
Hepaticojejunostomy without suture

Kalinauskaite, N.; Piippo, S., 2000 :
Hepatics (Bryophyta) of Tohmajarvi, North Karelia, Finland

Soderstrom, Lars, 2000:
Hepatics from Changbai Mountain, Jilin Province, China

Gyarmati, Andrea, 2001:
Hepatiques de Cote-d'Ivoire, recoltes du R. P. E. Assel

Haeussinger, D., 2002:
Hepatische Enzephalopathie

Yapar, M.; Guney, C.; Basustaoglu, A.; Kubar, A., 2001:
Hepatit B e antijen gen bolgesinin Escherichia coli'de ekspresyonu

Bulut, Y.; Doymaz, M.-Ziya, 2001:
Hepatit B virus core antijeni (HBcAg) geninin Escherichia coli'de klonlanmasi

Taysi, B.-Nuri; Aybay, C., 2001:
Hepatit B virus yuzey antijeninin saptanmasina yonelik ELISA tani kiti yapilmasi ve degerlendirilmesi

Nascimento, A.-Stilhano; Moreira, R.-Celia, 2001:
Hepatite E: Atualizacao

Hezode, C.; Dhumeaux, D., 2002:
Hepatite chronique C a transaminases normales de facon repetee

Paride-Conte, Vinicio, 2000:
Hepatite cronica por virus C parte 1. Consideracoes gerais

Mari, J.Y.; Guy, C.; Beyens, M.N.; Ollagnier, M., 2000:
Hepatite medicamenteuse d'apparition retardee. Evoquer le role de l'association amoxicilline-acide clavulanique

Nicand, E.; Grandadam, M.; Ramadani, Q.; Ibrahime, D.; Preteni, E.; Buisson, Y.; Rey, J.L.; Teyssou, R., 2000:
Hepatites virales epidemiques dans la region de Mitrovica, Kosovo

Akpek, Görgün.; Boitnott, J.K.; Lee, L.A.; Hallick, J.P.; Torbenson, M.; Jacobsohn, D.A.; Arai, S.; Anders, V.; Vogelsang, G.B., 2002:
Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion

Loupa, C.; Voyatzoglou, D., 1998:
Hepatitis A

Parment, P.-Arne; Emilsson, H., 2002:
Hepatitis A after a single dose of an inactivated hepatitis A vaccine

Domart, M.; Mlika Cabanne, N.; Henzel, D.; Pouliquen, A.; Florentin, A.; Marande, J.L.; Xerri, B.; Aufrere, A.; Larouze, B.; Occupational Health Physicians, O.P.ris Hospital (A.H.), 1999:
Hepatitis A among health workers in Paris hospitals

Lopalco, P.-Luigi; Salleras, L.; Barbuti, S.; Germinario, C.; Bruguera, M.; Buti, M.; Dominguez, A., 2000:
Hepatitis A and B in children and adolescents: What can we learn from Puglia (Italy) and Catalonia (Spain)?

Sansom, S.; Rudy, E.; Strine, T.; Douglas, W., 2003:
Hepatitis A and B vaccination in a sexually transmitted disease clinic for men who have sex with men

Czeschinski, P.A.; Binding, N.; Witting, U., 2000:
Hepatitis A and hepatitis B vaccinations: Immunogenicity of combined vaccine and of simultaneously or separately applied single vaccines

Aribas, E.T.rk; Altindis, M.; Koc, H.; Bitirgen, M., 1999:
Hepatitis A and hepatitis E seroprevalence of children admitted for complaints other than jaundice in Konya region

Gdalevic, M.; Grotto, I.; Mandel, Y.; Mimouni, D.; Shemer, J.; Ashkenazi, I., 1998:
Hepatitis A antibody prevalence among young adults in Israel - the decline continues

Van Damme, P.; Banatvala, J.; Fay, O.; Iwarson, S.; Mcmahon, B.; Van Herck, K.; Shouval, D.; Bonanni, P.; Connor, B.; Cooksley, G.; Leroux Roels, G.; Von Sonnenburg, F.; International Consensus Group, O.H.patitis A.Virus Immunity, 2003:
Hepatitis A booster vaccination: Is there a need?

Kanra, Güler.; Yalcin, Sül.S.; Kara, A.; Ozmert, E.; Yurdakök, K., 2002:
Hepatitis A booster vaccine in children after infant immunization

Kaic, B.; Borcic, B.; Ljubicic, M.; Brkic, I.; Mihaljevic, I., 2001:
Hepatitis A control in a refugee camp by active immunization

Brown, G.R.; Persley, K., 2002:
Hepatitis A epidemic in the elderly

Amin, J.; Gilbert, G.L.; Escott, R.G.; Heath, T.C.; Burgess, M.A., 2001:
Hepatitis A epidemiology in Australia: national seroprevalence and notifications

Ferguson, M.; Sands, D.; Lelie, N., 2001:
Hepatitis A immunoglobulin: an international collaborative study to establish the second international standard

Tefanova, V.T.; Tallo, T.G.; Priĭmiagi, L.S.; Kikosh, G.V.; Krupskaia, L.M.; Lisitsyna, S.A.; Noorlind, I.P., 2002:
Hepatitis A in Estonia (1990-1999)

Tapia-Conyer, R.; Santos, J.I.; Cavalcanti, A.M.; Urdaneta, E.; Rivera, L.; Manterola, A.; Potin, M.; Ruttiman, R.; Tanaka Kido, J., 1999:
Hepatitis A in Latin America: a changing epidemiologic pattern

Conaty, S.; Bird, P.; Bell, G.; Kraa, E.; Grohmann, G.; McAnulty, J.M., 2000:
Hepatitis A in New South Wales, Australia from consumption of oysters: the first reported outbreak

Al-Faleh, F.Z.; Al-Jeffri, M.H.; Ramia, S.T.; Al-Rashed, R.S.; Arif, M.A.; Mohammed, O.M.; Bakhsh, M.H.; Al-Freihi, H.M.; Aljumah, A.A.; Rezeig, M.A.; Traif, I.H.; Al-Swailem, A.M.; Mishkkhas, A.A.; Yasin, T.; Mirdad, S.E.; Ayoola, A.E., 1999:
Hepatitis A in Saudi Arabia: A comparative sero-epidemiological study

Glas, C.; Hotz, P.; Steffen, R., 2001:
Hepatitis A in workers exposed to sewage: a systematic review

Struchiner, C.J.; de Almeida, L.M.; de Azevedo, R.S.; Massad, E., 1999:
Hepatitis A incidence rate estimates from a pilot seroprevalence survey in Rio de Janeiro, Brazil

Sridharan, S.; Mossad, S.; Hoffman, G., 2000:
Hepatitis A infection mimicking adult onset Still's disease

Villar, L.Melo.; Esteves da Costa, M.do.Carmo.; de Paula, V.Salete.; Gaspar, A.Maria.Coimbra., 2002:
Hepatitis a outbreak in a public school in Rio de Janeiro, Brazil

Sadetzki, S.; Rostmi, N.; Modan, B., 1999:
Hepatitis A outbreak originating in a day care center: A community case report

Shaw, D.D.; Whiteman, D.C.; Merritt, A.D.; el-Saadi, D.M.; Stafford, R.J.; Heel, K.; Smith, G.A., 1999:
Hepatitis A outbreaks among illicit drug users and their contacts in Queensland, 1997

Basaran, G.; Buyukbese, M.A.if; Ozturk, R., 1998:
Hepatitis A risk factors in nurses and office workers

Antaki, N.; Kebbewar, M.K., 2000:
Hepatitis A seroprevalence rate in Syria

Tanaka, Jorge, 2000:
Hepatitis A shifting epidemiology in Latin America

Cianciara, Janusz, 2000:
Hepatitis A shifting epidemiology in Poland and Eastern Europe

Barzaga, Nina Gloriani, 2000:
Hepatitis A shifting epidemiology in South-East Asia and China

Tufenkeji, Haysam, 2000:
Hepatitis A shifting epidemiology in the Middle East and Africa

Rhodes, S.D.; Yee, L.J.; Hergenrather, K.C., 2003:
Hepatitis A vaccination among young African American men who have sex with men in the deep south: psychosocial predictors

Allard, R.; Beauchemin, J.; Bedard, L.; Dion, R.; Tremblay, M.; Carsley, J., 2001:
Hepatitis A vaccination during an outbreak among gay men in Montreal, Canada, 1995-1997

Nebbia, G.; Giacchino, R.; Soncini, R.; Ramaccioni, V.; Timitilli, A.; Zanetti, A.R., 1999:
Hepatitis A vaccination in chronic carriers of hepatitis B virus

Fiore, A.E.; Shapiro, C.N.; Sabin, K.; Labonte, K.; Darling, K.; Culver, D.; Bell, B.P.; Margolis, H.S., 2003:
Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster dose

Bell, Beth, P., 2000:
Hepatitis A vaccine

Williams, J.; Fox Leyva, L.; Christensen, C.; Fisher, D.; Schlicting, E.; Snowball, M.; Negus, S.; Mayers, J.; Koller, R.; Stout, R., 2000:
Hepatitis A vaccine administration: Comparison between jet-injector and needle injection

Giacchino, R.; Timitilli, A.; Castellano, E.; D.R.cco, M.; Fiore, P.; Soncini, R.; Romanò, L., 2001:
Hepatitis A vaccine in pediatric patients affected by metabolic liver diseases

Williams, J.L.; Bruden, D.A.; Cagle, H.H.; McMahon, B.J.; Negus, S.E.; Christensen, C.J.; Snowball, M.M.; Bulkow, L.R.; Fox-Leyva, L.K., 2003:
Hepatitis A vaccine: immunogenicity following administration of a delayed immunization schedule in infants, children and adults

Kanda, T.; Yokosuka, O.; Kato, N.; Imazeki, F.; Fujiwara, K.; Kawai, S.; Saisho, H.; Omata, M., 2003:
Hepatitis A virus VP3 may activate serum response element associated transcription

Graff, J.; Richards, O.C.; Swiderek, K.M.; Davis, M.T.; Rusnak, F.; Harmon, S.A.; Jia, X.Y.; Summers, D.F.; Ehrenfeld, E., 1999:
Hepatitis A virus capsid protein VP1 has a heterogeneous C terminus

Tseng, H.Y.; Lu, C.Y.; Lee, C.Y.; Yeh, C.C.; Lin, S.C.; Shih, W.Y.; Wu, S.Y.; Chang, M.H.; Huang, L.M., 2001:
Hepatitis A virus infection in Taipei in 1999

Chudy, M.; Stahl-Hennig, C.; Berger, A.; Nübling, C.Micha.; Hunsmann, G.; Rabenau, H.F.; Löwer, J., 2002:
Hepatitis A virus infection in tamarins: experimental transmission via contaminated factor VIII concentrates

Brack, K.; Berk, I.; Magulski, T.; Lederer, Jörg.; Dotzauer, A.; Vallbracht, A., 2002:
Hepatitis A virus inhibits cellular antiviral defense mechanisms induced by double-stranded RNA

Pintó, R.M.; Guix, S.; González-Dankaart, J.F.; Caballero, S.; Sánchez, G.; Guo, K-Jian.; Ribes, E.; Bosch, A., 2002 :
Hepatitis A virus polyprotein processing by Escherichia coli proteases

Totsuka, A.; Moritsugu, Y., 1999:
Hepatitis A virus proteins

Bishop, N.E., 2000:
Hepatitis A virus replication: an intermediate in the uncoating process

Wünschmann, S.; Becker, B.; Vallbracht, A., 2002:
Hepatitis A virus suppresses monocyte-to-macrophage maturation in vitro

Funkhouser, A.W.; Schultz, D.E.; Lemon, S.M.; Purcell, R.H.; Emerson, S.U., 1999:
Hepatitis A virus translation is rate-limiting for virus replication in MRC-5 cells

Cederna, J.B.; Klinzman, D.; Stapleton, J.T., 1999:
Hepatitis A virus-specific humoral and cellular immune responses following immunization with a formalin-inactivated hepatitis A vaccine

Dotzauer, A.; Gebhardt, U.; Bieback, K.; Göttke, U.; Kracke, A.; Mages, J.; Lemon, S.M.; Vallbracht, A., 2000:
Hepatitis A virus-specific immunoglobulin A mediates infection of hepatocytes with hepatitis A virus via the asialoglycoprotein receptor

Koff, R.S., 2002:
Hepatitis A, hepatitis B, and combination hepatitis vaccines for immunoprophylaxis: an update

Vesely, D.L.; Dilley, R.W.; Duckworth, W.C.; Paustian, F.F., 1999:
Hepatitis A-induced diabetes mellitus, acute renal failure, and liver failure

Taliani, G.; Gaeta, G.B.ttista, 2003:
Hepatitis A: Post-exposure prophylaxis

Chung, T-Wook.; Lee, Y-Choon.; Ko, J-Heon.; Kim, C-Ho., 2003:
Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells

Ammon, A.; Reichart, P.A.; Pauli, G.; Petersen, L.R., 2000:
Hepatitis B and C among Berlin dental personnel: incidence, risk factors, and effectiveness of barrier prevention measures

Vellinga, A.; Van Damme, P.; Meheus, A., 1999:
Hepatitis B and C in institutions for individuals with intellectual disability

Souza, K.P.; Luz, Jônio.A.; Teles, S.A.; Carneiro, M.A.S.; Oliveira, L.A.; Gomes, A.S.; Dias, Márcia.A.; Gomes, S.A.; Yoshida, C.F.T.; Martins, R.M.B., 2003:
Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles

Reshetnikov, O.V.; Khryanin, A.A.; Teinina, T.R.; Krivenchuk, N.A.; Zimina, I.Y., 2001:
Hepatitis B and C seroprevalence in Novosibirsk, western Siberia

Matsushima, M.; Sugitani, M.; Sheikh, A.; Suzuki, K., 2002:
Hepatitis B and C virus carriers in a healthy population in Bangladesh

Sithebe, N.P.; Kramvis, A.; Kew, M.C.; Bhimma, R.; Coovadia, H.M.; Naidoo, P., 2002:
Hepatitis B and C virus co-infection in black children with membranous nephropathy

Jin, Y.; Abe, K.; Sato, Y.; Aita, K.; Irie, H.; Shiga, J., 2002:
Hepatitis B and C virus infection and p53 mutations in human hepatocellular carcinoma in Harbin, Heilongjian Province, China

Cucuianu, A.; Patiu, M.; Duma, M.; Basarab, C.; Soritau, O.; Bojan, A.; Vasilache, A.; Mates, M.; Petrov, L., 1999:
Hepatitis B and C virus infection in Romanian non-Hodgkin's lymphoma patients

Lodenyo, H.; Schoub, B.; Ally, R.; Kairu, S.; Segal, I., 2000:
Hepatitis B and C virus infections and liver function in AIDS patients at Chris Hani Baragwanath Hospital, Johannesburg

Smikle, M.; Dowe, G.; Hylton-Kong, T.; Williams, E., 2001:
Hepatitis B and C viruses and sexually transmitted disease patients in Jamaica

Kuper, H.E.; Tzonou, A.; Kaklamani, E.; Hadziyannis, S.; Tasopoulos, N.; Lagiou, P.; Trichopoulos, D.; Stuver, S., 2000:
Hepatitis B and C viruses in the etiology of hepatocellular carcinoma; A study in Greece using third-generation assays

Pyle, G., F.; Oreskovic, S.; Begovac, J.; Thompson, C., 2000:
Hepatitis B and HIV/AIDS in Zagreb: A district level analysis

Kitchen, Alan, 1998:
Hepatitis B and blood safety

Blakely, T.A.; Bates, M.N.; Baker, M.G.; Tobias, M., 1999:
Hepatitis B carriage explains the excess rate of hepatocellular carcinoma for Maori, Pacific Island and Asian people compared to Europeans in New Zealand

Pichainarong, N.; Chaveepojnkamjorn, W.; Luksamijarulkul, P.; Sujirarat, D.; Keereecamsuk, T., 2003:
Hepatitis B carrier among married hilltribe women in northern Thailand

Jahani, M.R.za; Motevalian, S.A.bas; Mahmoodi, M., 2003:
Hepatitis B carriers in large vehicle drivers of Iran

Van Damme, P.; Vorsters, A., 2002:
Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001

Christensen, P.B.; Titlestad, I.L.; Homburg, K.M.; Georgsen, J.; Kristensen, T., 2001:
Hepatitis B core antibodies in Danish blood donors: A surrogate marker of risk behaviour

de Villa, V.H.; Chen, Y-Sen.; Chen, C-Long., 2003:
Hepatitis B core antibody-positive grafts: recipient's risk

Manigold, T.; Böcker, U.; Chen, J.; Gundt, J.; Traber, P.; Singer, M.V.; Rossol, S., 2003:
Hepatitis B core antigen is a potent inductor of interleukin-18 in peripheral blood mononuclear cells of healthy controls and patients with hepatitis B infection

Pumpens, P.; Grens, E., 1999:
Hepatitis B core particles as a universal display model: A structure-function basis for development

Rambusch, E.G.; Nashan, B.; Tillmann, H.L.; Boeker, K.H.W.; Schlitt, H.J.; Maschek, H.; Raab, R.; Manns, M.P., 1998:
Hepatitis B de-novo infection following liver transplantation indicating the need for active hepatitis B immunization of liver transplant candidates

Kato, H.; Orito, E.; Gish, R.G.; Bzowej, N.; Newsom, M.; Sugauchi, F.; Suzuki, S.; Ueda, R.; Miyakawa, Y.; Mizokami, M., 2002:
Hepatitis B e antigen in sera from individuals infected with hepatitis B virus of genotype G

Song, B.C.; Suh, D.J.; Lee, H.C.; Chung, Y.H.; Lee, Y.S., 2000:
Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea

Farrell, Geoffrey, 2000:
Hepatitis B e antigen seroconversion: Effects of lamivudine alone or in combination with interferon alpha

Chan, H.L.; Leung, N.W.; Hussain, M.; Wong, M.L.; Lok, A.S., 2000:
Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong

Andre, Francis, 2000:
Hepatitis B epidemiology in Asia, the Middle East and Africa

Tanaka, Jorge, 2000:
Hepatitis B epidemiology in Latin America

Magdzik, Wieslaw, 2000:
Hepatitis B epidemiology in Poland, Central and Eastern Europe and the Newly Independent States

Lin, C.L.n; Liao, L.Y.ng; Liu, C.J.n; Chen, P.J.r; Lai, M.Y.ng; Kao, J.H.rng; Chen, D.S.inn, 2002:
Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B

Kao, J.H.rng; Wu, N.H.i; Chen, P.J.r; Lai, M.Y.ng; Chen, D.S.inn, 2000:
Hepatitis B genotypes and the response to interferon therapy

Kao, J.H.rng; Chen, P.J.r; Lai, M.Y.ng; Chen, D.S.inn, 2000:
Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

Ray, S.; Samuel, T.; Hawker, J.; Smith, S., 2002:
Hepatitis B immunisation in renal units in the United Kingdom: questionnaire study

Richardson, G.; Evans, M.R.; Westmoreland, D., 2001:
Hepatitis B immunisation of household contacts: retrospective study of vaccine coverage

Montesano, R., 2002:
Hepatitis B immunization and hepatocellular carcinoma: The Gambia Hepatitis Intervention Study

Jurema, M.W.; Polaneczky, M.; Ledger, W.J., 2001:
Hepatitis B immunization in postpartum women

Papaevangelou, George, 1998:
Hepatitis B immunization programme: Lessons learnt in Greece

Sánchez-Fueyo, A.; Rimola, A.; Grande, L.; Costa, J.; Mas, A.; Navasa, M.; Cirera, I.; Sánchez-Tapias, J.M.; Rodés, J., 2000:
Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation

Mele, A.; Stroffolini, T.; Zanetti, A.R., 2002:
Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination

Uchaikin, V.F.; Smirnov, A.V.; Cherednichenko, T.V.; Syr'eva, T.N.; Rosina, A.L.; Kudryavtsev, A.N., 1999:
Hepatitis B in children with somatic pathology

Oliveira, L.H.; Silva, I.R.; Xavier, B.L.; Cavalcanti, S.M., 2001:
Hepatitis B infection among patients attending a sexually transmitted diseases clinic in Rio de Janeiro, Brazil

Teo, E.K.; Ostapowicz, G.; Hussain, M.; Lee, W.M.; Fontana, R.J.; Lok, A.S., 2001:
Hepatitis B infection in patients with acute liver failure in the United States

Lok, Anna-Suk-Fong, 2000:
Hepatitis B infection: pathogenesis and management

Pierce, R.L.; Smith, S.; Rowe-West, B.; Sterritt, B., 1999:
Hepatitis B maternal screening, infant vaccination, and infant prophylaxis practices in North Carolina

Fujisawa, T.; Inui, A.; Komatsu, H.; Ohkawa, T.; Sogo, T.; Miyagawa, Y., 1999:
Hepatitis B precore mutant in children with chronic hepatitis B virus infection

Brabin, B.; Beeching, N.J.; Bunn, J.E.G.; Cooper, C.; Gardner, K.; Hart, C.A., 2002:
Hepatitis B prevalence among Somali households in Liverpool

Doutsos, J.; Dardavessis, T.; Grigoriadou, A.; Doutsou, K.; Tirodimos, E., 1998:
Hepatitis B prevalence among medical students of Aristotle University of Thessaloniki

Hernandez, M.T.; Klausner, J.D.; McFarland, W.; Wong, E.; Bolan, G.; Molitor, F.; Ruiz, J.D., 2000:
Hepatitis B prevalence in young women living in low-income areas: the population-based San Francisco Bay area's Young Women's Survey

Ostuni, P.; Botsios, C.; Punzi, L.; Sfriso, P.; Todesco, S., 2003:
Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate

Koff, Raymond, S., 2000:
Hepatitis B school-based vaccination programmes in the USA: A model for hepatitis A and B

Heijtink, R.A.; Van-Bergen, P.; Melber, K.; Janowicz, Z.A.; Osterhaus, A.D.M.E., 2002:
Hepatitis B surface antigen (HBsAg) derived from yeast cells (Hansenula polymorpha) used to establish an influence of antigenic subtype (adw2, adr, ayw3) in measuring the immune response after vaccination

Furusyo, N.; Hayashi, J.; Sawayama, Y.; Kishihara, Y.; Kashiwagi, S., 1999:
Hepatitis B surface antigen disappearance and hepatitis B surface antigen subtype: a prospective, long-term, follow-up study of Japanese residents of Okinawa, Japan with chronic hepatitis B virus infection

O'Brien, J.E., 2000:
Hepatitis B surface antigen: decreased need for confirmation of reactive results

Ly, D.; Yee, H.F.Jr.; Brezina, M.; Martin, P.; Gitnick, G.; Saab, S., 2002:
Hepatitis B surface antigenemia in chronic hemodialysis patients: Effect of hepatitis B immunization

Lewin, S.; Walters, T.; Locarnini, S., 2002:
Hepatitis B treatment: Rational combination chemotherapy based on viral kinetic and animal model studies

Lauderdale, D.S.; Oram, R.J.; Goldstein, K.P.; Daum, R.S., 1999:
Hepatitis B vaccination among children in inner-city public housing, 1991-1997

Hagan, H.; Thiede, H.; McGough, J.P.; Alexander, E.Russell., 2002:
Hepatitis B vaccination among research participants, Seattle, Washington

Geier, D.A.; Geier, M.R., 2002:
Hepatitis B vaccination and adult associated gastrointestinal reactions: a follow-up analysis

Touzé, E.; Fourrier, A.; Rue-Fenouche, Cécile.; Rondé-Oustau, Véronique.; Jeantaud, I.; Bégaud, B.; Alpérovitch, A., 2002:
Hepatitis B vaccination and first central nervous system demyelinating event: a case-control study

Chang, M.H.; Shau, W.Y.; Chen, C.J.; Wu, T.C.; Kong, M.S.; Liang, D.C.; Hsu, H.M.; Chen, H.L.; Hsu, H.Y.; Chen, D.S., 2000:
Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls

Ascherio, A.; Zhang, S.M.; Hernán, M.A.; Olek, M.J.; Coplan, P.M.; Brodovicz, K.; Walker, A.M., 2001:
Hepatitis B vaccination and the risk of multiple sclerosis

Yusuf, H.; Daniels, D.; Mast, E.E.; Coronado, V., 2001:
Hepatitis B vaccination coverage among United States children

Mak, R.; Traen, A.; Claeyssens, M.; Van Renterghem, L.; Leroux-Roels, G.; Van Damme, P., 2003:
Hepatitis B vaccination for sex workers: do outreach programmes perform better?

Rhodes, S., D.; Diclemente, R., J.; Yee, L., J.; Hergenrather, K., C., 2000:
Hepatitis B vaccination in a high risk MSM population: The need for vaccine education

Somjee, S.; Pai, S.; Kelkar, R.; Advani, S., 1999:
Hepatitis B vaccination in children with acute lymphoblastic leukemia: Results of an intensified immunization schedule

Wu, J.S.; Hwang, L.Y.; Goodman, K.J.; Beasley, R.P., 1999:
Hepatitis B vaccination in high-risk infants: 10-year follow-up

Viviani, S.; Jack, A.; Hall, A.J.; Maine, N.; Mendy, M.; Montesano, R.; Whittle, H.C., 1999:
Hepatitis B vaccination in infancy in The Gambia: Protection against carriage at 9 years of age

Vellinga, A.; Van Damme, P.; Weyler, J.J.; Vranckx, R.; Meheus, A., 1999:
Hepatitis B vaccination in mentally retarded: Effectiveness after 11 years

Lee, S.D.ng; Chan, C.Y.; Yu, M.I.; Lu, R.H.a; Chang, F.Y.ung; Lo, K.J.ei, 1999:
Hepatitis B vaccination in patients with chronic hepatitis C

Ingardia, C.J.; Kelley, L.; Steinfeld, J.D.; Wax, J.R., 1999:
Hepatitis B vaccination in pregnancy: Factors influencing efficacy

Golebiowska, M.; Kardas Sobantka, D.; Chlebna Sokol, D.; Sabanty, W., 1999:
Hepatitis B vaccination in preterm infants

Awofeso, N., 2002:
Hepatitis B vaccination in prisons

Wilson, B.C.; Moyer, L.; Schmid, G.; Mast, E.; Voigt, R.; Mahoney, F.; Margolis, H., 2001:
Hepatitis B vaccination in sexually transmitted disease (STD) clinics: a survey of STD programs

Mast, E.E.; Williams, I.T.; Alter, M.J.; Margolis, H.S., 1998:
Hepatitis B vaccination of adolescent and adult high-risk groups in the United States

Thompson, S.C.; Norris, M., 1999:
Hepatitis B vaccination of personnel employed in Victorian hospitals: are those at risk adequately protected?

Clark, S.J.; Cabana, M.D.; Malik, T.; Yusuf, H.; Freed, G.L., 2001:
Hepatitis B vaccination practices in hospital newborn nurseries before and after changes in vaccination recommendations

Geier, M.R.; Geier, D.A., 2002:
Hepatitis B vaccination safety

Francois, G.; Hallauer, J.; Van Damme, P., 2002:
Hepatitis B vaccination: How to reach risk groups

Linder, N.; Vishne, T.H.; Levin, E.; Handsher, R.; Fink-Kremer, I.; Waldman, D.; Levine, A.; Ashkenazi, S.; Sirota, L., 2002:
Hepatitis B vaccination: long-term follow-up of the immune response of preterm infants and comparison of two vaccination protocols

Mittal, S.K., 2003:
Hepatitis B vaccination: Myths and controversies

Jefferson, T.; Traversa, G., 2002:
Hepatitis B vaccination: risk-benefit profile and the role of systematic reviews in the assessment of causality of adverse events following immunisation

Halsey, N.A.; Moulton, L.H.; O'Donovan, J.C.; Walcher, J.R.; Thoms, M.L.; Margolis, H.S.; Krause, D.S., 1999:
Hepatitis B vaccine administered to children and adolescents at yearly intervals

Campins Martí, M.; Moraga Llop, F.A., 1999 :
Hepatitis B vaccine and multiple sclerosis

Alves, A.S.; Nascimento, C.M.; Granato, C.H.; Sato, H.K.; Morgato, M.F.; Pannuti, C.S., 2001:
Hepatitis B vaccine in infants: a randomized controlled trial comparing gluteal versus anterolateral thigh muscle administration

Noh, K.W.; Poland, G.A.; Murray, J.A., 2003:
Hepatitis B vaccine nonresponse and celiac disease

Karaali Savrun, F.; Altintas, A.; Saip, S.; Siva, A., 2001:
Hepatitis B vaccine related-myelitis?

Dow, B.C.; Yates, P.; Galea, G.; Munro, H.; Buchanan, I.; Ferguson, K., 2002:
Hepatitis B vaccines may be mistaken for confirmed hepatitis B surface antigen-positive blood donors

Coates, T.; Wilson, R.; Patrick, G.; Andre, F.; Watson, V., 2001:
Hepatitis B vaccines: Assessment of the seroprotective efficacy of two recombinant DNA vaccines

Choi, B.H.; Choi, M.; Jeon, H.Y.; Rho, H.M., 2001:
Hepatitis B viral X protein overcomes inhibition of E2F1 activity by pRb on the human Rb gene promoter

Kwon, J.Ah.; Rho, H.Mo., 2002:
Hepatitis B viral core protein activates the hepatitis B viral enhancer II/pregenomic promoter through the nuclear factor kappaB binding site

Hui, E.K.; Yi, Y.S.; Lo, S.J., 1999:
Hepatitis B viral core proteins with an N-terminal extension can assemble into core-like particles but cannot be enveloped

Kao, Jia Horng, 2002:
Hepatitis B viral genotypes: Clinical relevance and molecular characteristics

Chen, K.L.n; Chen, C.M.ng; Shih, C.M.ng; Huang, H.L.n; Lee, Y.H.a Wu; Chang, C.; Lo, S.J., 2001:
Hepatitis B viral polymerase fusion proteins are biologically active and can interact with the hepatitis C virus core protein in vivo

Ogden, S.K.; Lee, K.C.; Barton, M.C., 2000:
Hepatitis B viral transactivator HBx alleviates p53-mediated repression of alpha-fetoprotein gene expression

Gandhi, M.J.; Yang, G.G.; Mcmahon, B.J.; Vyas, G.N., 2000:
Hepatitis B virions isolated with antibodies to the pre-S1 domain reveal occult viremia by PCR in Alaska native HBV carriers who have seroconverted

Thibault, V.; Benhamou, Y.; Seguret, C.; Bochet, M.; Katlama, C.; Bricaire, F.; Opolon, P.; Poynard, T.; Agut, H., 1999:
Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus

Ren, S.; Nassal, M., 2001:
Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors

Seo, Y.; Yoon, S.; Nakaji, M.; Yano, Y.; Nagano, H.; Ninomiya, T.; Hayashi, Y.; Kasuga, M., 2003:
Hepatitis B virus DNA in anti-HBe-positive asymptomatic carriers

Gutiérrez, C.; León, G.; Loureiro, C.L.; Uzcátegui, N.; Liprandi, F.; Pujol, F.H., 1999:
Hepatitis B virus DNA in blood samples positive for antibodies to core antigen and negative for surface antigen

Mendy, M.E.; Fortuin, M.; Hall, A.J.; Jack, A.D.; Whittle, H.C., 1999:
Hepatitis B virus DNA in relation to duration of hepatitis B surface antigen carriage

Kazemi Shirazi, L.; Petermann, D.; Muller, C., 2000:
Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C

Gonçales, F.Lopes.; Pereira, J.Silveira.Felix.; D.S.lva, C.; Thomaz, G.Roberto.; Pavan, M.Helena.Postal.; Fais, V.Cristina.; Magna, L.Alberto.; Gonçales, N.Sellan.Lopes., 2003:
Hepatitis B virus DNA in sera of blood donors and of patients infected with hepatitis C virus and human immunodeficiency virus

Owiredu, W.K.B.A.; Kramvis, A.; Kew, M.C., 2001:
Hepatitis B virus DNA in serum of healthy black African adults positive for hepatitis B surface antibody alone: Possible association with recombination between genotypes A and D

Stefas, I.; Rucheton, M.; D'Angeac, A.D.; Morel-Baccard, C.; Seigneurin, J.M.; Zarski, J.P.; Martin, M.; Cerutti, M.; Bossy, J.P.; Missé, D.; Graafland, H.; Veas, F., 2000:
Hepatitis B virus Dane particles bind to human plasma apolipoprotein H

Stohwasser, R.; Holzhütter, H-Georg.; Lehmann, U.; Henklein, P.; Kloetzel, P.M., 2003:
Hepatitis B virus HBx peptide 116-138 and proteasome activator PA28 compete for binding to the proteasome alpha4/MC6 subunit

Bouchard, M.; Giannakopoulos, S.; Wang, E.H.; Tanese, N.; Schneider, R.J., 2001:
Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway

Lu, X.; Lu, Y.; Geschwindt, R.; Dwek, R.A.; Block, T.M., 2001:
Hepatitis B virus MHBs antigen is selectively sensitive to glucosidase-mediated processing in the endoplasmic reticulum

Mathet, V.L.; Feld, M.; Espínola, L.; Sánchez, D.O.; Ruiz, V.; Mandó, O.; Carballal, G.; Quarleri, J.F.; D'Mello, F.; Howard, C.R.; Oubiña, J.R., 2002:
Hepatitis B virus S gene mutants in a patient with chronic active hepatitis with circulating Anti-HBs antibodies

Venard, V.; Corsaro, D.; Kajzer, C.; Bronowicki, J.P.; L.F.ou, A., 2000:
Hepatitis B virus X gene variability in French-born patients with chronic hepatitis and hepatocellular carcinoma

Shih, W-Ling.; Kuo, M-Liang.; Chuang, S-En.; Cheng, A-Lii.; Doong, S-Lian., 2003:
Hepatitis B virus X protein activates a survival signaling by linking SRC to phosphatidylinositol 3-kinase

Tarn, C.; Zou, L.; Hullinger, R.L.; Andrisani, O.M., 2002:
Hepatitis B virus X protein activates the p38 mitogen-activated protein kinase pathway in dedifferentiated hepatocytes

Madden, C.R.; Finegold, M.J.; Slagle, B.L., 2001:
Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions

Leupin, O.; Bontron, Séverine.; Strubin, M., 2003:
Hepatitis B virus X protein and simian virus 5 V protein exhibit similar UV-DDB1 binding properties to mediate distinct activities

Bontron, Séverine.; Lin-Marq, N.; Strubin, M., 2002:
Hepatitis B virus X protein associated with UV-DDB1 induces cell death in the nucleus and is functionally antagonized by UV-DDB2

Rahmani, Z.; Huh, K.W.; Lasher, R.; Siddiqui, A., 2000:
Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential

Tarn, C.; Lee, S.; Hu, Y.; Ashendel, C.; Andrisani, O.M., 2001:
Hepatitis B virus X protein differentially activates RAS-RAF-MAPK and JNK pathways in X-transforming versus non-transforming AML12 hepatocytes

Lee, S.; Tarn, C.; Wang, W-Horng.; Chen, S.; Hullinger, R.L.; Andrisani, O.M., 2002:
Hepatitis B virus X protein differentially regulates cell cycle progression in X-transforming versus nontransforming hepatocyte (AML12) cell lines

Yoo, Y-Gun.; Oh, S.Hyun.; Park, E.Sook.; Cho, H.; Lee, N.; Park, H.; Kim, D.Kyong.; Yu, D-Yeul.; Seong, J.Kyung.; Lee, M-Ock., 2003 :
Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1alpha through activation of mitogen-activated protein kinase pathway

Chen, W.N.ng; Oon, C.J.n; Goo, K.S.m, 2001:
Hepatitis B virus X protein in the proteasome of mammalian cells: Defining the targeting domain

Qiao, L.; Leach, K.; McKinstry, R.; Gilfor, D.; Yacoub, A.; Park, J.S.; Grant, S.; Hylemon, P.B.; Fisher, P.B.; Dent, P., 2001:
Hepatitis B virus X protein increases expression of p21(Cip-1/WAF1/MDA6) and p27(Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression

Lee, M.-Ock; Choi, Y.-Hee; Shin, E.-Cheol; Kang, H.-Jin; Kim, Y.-Mee; Jeong, S.-Yon; Seong, J.-Kyung; Yu, D.-Yeul; Cho, H.; Park, J.-Han; Kim, S.-Jong, 2002:
Hepatitis B virus X protein induced expression of interleukin 18 (IL-18): A potential mechanism for liver injury caused by hepatitis B virus (HBV) infection

Lee, M.O.; Kang, H.J.; Cho, H.; Shin, E.C.; Park, J.H.; Kim, S.J., 2001:
Hepatitis B virus X protein induced expression of the Nur77 gene

Yi, Y-Su.; Park, S.Gyoo.; Byeon, S.Moo.; Kwon, Y-Guen.; Jung, G., 2003:
Hepatitis B virus X protein induces TNF-alpha expression via down-regulation of selenoprotein P in human hepatoma cell line, HepG2

Shirakata, Y.; Koike, K., 2003:
Hepatitis B virus X protein induces cell death by causing loss of mitochondrial membrane potential

Jia, L.; Wang, X.W.i; Harris, C.C., 1999:
Hepatitis B virus X protein inhibits nucleotide excision repair

Hu, Z.; Zhang, Z.; Doo, E.; Coux, O.; Goldberg, A.L.; Liang, T.J., 1999:
Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex

Kong, H.Jeong.; Park, M.Jung.; Hong, S.; Yu, H.Jung.; Lee, Y.Chul.; Choi, Y.Hyun.; Cheong, J., 2003:
Hepatitis B virus X protein regulates transactivation activity and protein stability of the cancer-amplified transcription coactivator ASC-2

Majano, P.; Lara-Pezzi, E.; López-Cabrera, M.; Apolinario, A.; Moreno-Otero, R.; García-Monzón, C., 2001:
Hepatitis B virus X protein transactivates inducible nitric oxide synthase gene promoter through the proximal nuclear factor kappaB-binding site: evidence that cytoplasmic location of X protein is essential for gene transactivation

Amaro, M.J.; Bartolomé, J.; Carreño, V., 1999:
Hepatitis B virus X protein transactivates the inducible nitric oxide synthase promoter

Murakami, Seishi, 2001:
Hepatitis B virus X protein: A multifunctional viral regulator

Murakami, S., 1999:
Hepatitis B virus X protein: structure, function and biology

Grob, P.J.; Frei, P.C., 1998:
Hepatitis B virus and pathogeneses

Sakugawa, H.; Nakasone, H.; Nakayoshi, T.; Kawakami, Y.; Yamashiro, T.; Maeshiro, T.; Kinjo, F.; Saito, A.; Zukeran, H., 2001:
Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection

Cao, T.; Lazdina, U.; Desombere, I.; Vanlandschoot, P.; Milich, D.R.; Sällberg, M.; Leroux-Roels, G., 2001:
Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model

Tan, W.Siang.; Dyson, M.R.; Murray, K., 2003:
Hepatitis B virus core antigen: enhancement of its production in Escherichia coli, and interaction of the core particles with the viral surface antigen

Gerner, P.; Lausch, E.; Friedt, M.; Tratzmueller, R.; Spangenberg, C.; Wirth, S., 1999:
Hepatitis B virus core promoter mutations in children with multiple anti-HBe/HBeAg reactivations result in enhanced promoter activity

Huang, C.J.ng; Chen, Y.H.n; Ting, L.P.i, 2000:
Hepatitis B virus core protein interacts with the C-terminal region of actin-binding protein

Kim, J-Hwan.; Kang, S.; Kim, J.; Ahn, B-Yoon., 2003:
Hepatitis B virus core protein stimulates the proteasome-mediated degradation of viral X protein

Fernández, M.; Quiroga, J.Antonio.; Carreño, V., 2003:
Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins

Baumeister, M.A.; Medina Selby, A.; Coit, D.; Nguyen, S.; George Nascimento, C.; Gyenes, A.; Valenzuela, P.; Kuo, G.; Chien, D.Y., 2000:
Hepatitis B virus e antigen specific epitopes and limitations of commercial anti-HBe immunoassays

Rodríguez, L.; Collado-Mesa, F.; Aragón, U.; Díaz, B.; Rivero, J., 2000:
Hepatitis B virus exposure in human immunodeficiency virus seropositive Cuban patients

Preikschat, P.; Meisel, H.; Will, H.; Günther, S., 1999:
Hepatitis B virus genomes from long-term immunosuppressed virus carriers are modified by specific mutations in several regions

Li, W.; Ikematsu, H.; Yamaji, K.; Chong, Y.; Hayashi, J.; Kashiwagi, S., 2001:
Hepatitis B virus genomes of chronic hepatitis patients do not contain specific mutations related to acute exacerbation

Chu, C.J.n; Hussain, M.; Lok, A.S.F., 2002:
Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C

Mizokami, M.; Nakano, T.; Orito, E.; Tanaka, Y.; Sakugawa, H.; Mukaide, M.; Robertson, B.H., 1999:
Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns

Ding, X.; Mizokami, M.; Yao, G.; Xu, B.; Orito, E.; Ueda, R.; Nakanishi, M., 2001:
Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai, China

Sugauchi, F.; Chutaputti, A.; Orito, E.; Kato, H.; Suzuki, S.; Ueda, R.; Mizokami, M., 2002:
Hepatitis B virus genotypes and clinical manifestation among hepatitis B carriers in Thailand

Gandhe, S.S.; Chadha, M.S.; Arankalle, V.A., 2003:
Hepatitis B virus genotypes and serotypes in western India: lack of clinical significance

Westland, C.; Delaney, W.I.; Yang, H.; Chen, S.S.an; Marcellin, P.; Hadziyannis, S.; Gish, R.; Fry, J.; Brosgart, C.; Gibbs, C.; Miller, M.; Xiong, S., 2003:
Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil

Kato, H.; Ruzibakiev, R.; Yuldasheva, N.; Hegay, T.; Kurbanov, F.; Achundjanov, B.; Tuichiev, L.; Usuda, S.; Ueda, R.; Mizokami, M., 2002:
Hepatitis B virus genotypes in Uzbekistan and validity of two different systems for genotyping

Chu, C.J.n; Keeffe, E.B.; Han, S.H.y; Perrillo, R.P.; Min, A.D.; Soldevila Pico, C.; Carey, W.; Brown, R.S.J.; Luketic, V.A.; Terrault, N.; Lok, A.S.F.; The, U.S.H.v Epidemiology Study Group, 2003:
Hepatitis B virus genotypes in the United States: Results of a nationwide study

Lum, P.J.; Ochoa, K.C.; Hahn, J.A.; Page Shafer, K.; Evans, J.L.; Moss, A.R., 2003:
Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study

Feitelson, M.A., 1999:
Hepatitis B virus in hepatocarcinogenesis

Kawsar, M.; Goh, B.T., 2002:
Hepatitis B virus infection among Chinese residents in the United Kingdom

Ivic, I.; Banovic, I.; Bradaric, N., 1999:
Hepatitis B virus infection among pregnant women in Split region

Sugauchi, F.; Mizokami, M.; Orito, E.; Ohno, T.; Kato, H.; Maki, M.; Suzuki, H.; Ojika, K.; Ueda, R., 2000:
Hepatitis B virus infection among residents of a nursing home for the elderly: Seroepidemiological study and molecular evolutionary analysis

Kim, J.H.un; Bang, Y.J.e; Park, B.J.o; Yoo, T.; Kim, C.W.o; Kim, T.Y.u; Heo, D.S.og; Lee, H.S.k; Kim, N.K.eong, 2002:
Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case-control study

Kozik, C.A.; Vaughn, D.W.; Snitbhan, R.; Innis, B.L., 2000:
Hepatitis B virus infection in Thai children

Ni, Y.H.; Chang, M.H.; Huang, L.M.; Chen, H.L.; Hsu, H.Y.; Chiu, T.Y.; Tsai, K.S.; Chen, D.S., 2001:
Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination

Gjeruldsen, S.; Myrvang, B., 2002:
Hepatitis B virus infection in drug addicts: No acute fatalities, no chronicity and could have benefits

Ko, W.J.; Chou, N.K.an; Hsu, R.B.n; Chen, Y.S.arng; Wang, S.S.en; Chu, S.H.un; Lai, M.Y.ng, 2001:
Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area

Carrilho, Flair-Jose, 2001:
Hepatitis B virus infection in hemodialysis centers from Santa Catarina State, southern Brazil. Predictive risk factors for infection and molecular epidemiology

Fabrizi, F.; Lunghi, G.; Martin, P., 2002:
Hepatitis B virus infection in hemodialysis: recent discoveries

Giacchino, R.; Zancan, L.; Vajro, P.; Verucchi, G.; Resti, M.; Barbera, C.; Maccabruni, A.; Marcellini, M.; Balli, F.; Cascio, A.; Nebbia, G.; Crivellaro, C.; Bortolotti, F.; Clemente, M.G.; Bragetti, P.; Valentini, P.; Mazzoni, N.; Losurdo, G.; Cristina, E., 2001:
Hepatitis B virus infection in native versus immigrant or adopted children in Italy following the compulsory vaccination

Hartmann-Stühler, C.; Prange, R., 2001:
Hepatitis B virus large envelope protein interacts with gamma2-adaptin, a clathrin adaptor-related protein

Hui, E.K.; Chen, K.L.; Lo, S.J., 1999:
Hepatitis B virus maturation is affected by the incorporation of core proteins having a C-terminal substitution of arginine or lysine stretches

Sugauchi, F.; Orito, E.; Ichida, T.; Kato, H.; Sakugawa, H.; Kakumu, S.; Ishida, T.; Chutaputti, A.; Lai, C-Ling.; Ueda, R.; Miyakawa, Y.; Mizokami, M., 2002:
Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene

Lin, Z.M.i; Yatsuhashi, H.; Daikoku, M.; Hamada, R.; Nakao, R.; Fukuda, M.; Koga, M.; Yano, M., 2003:
Hepatitis B virus of genotype C persistence after recovery from acute hepatitis B virus infection in Japan

Shamay, M.; Barak, O.; Doitsh, G.; Ben-Dor, I.; Shaul, Y., 2002:
Hepatitis B virus pX interacts with HBXAP, a PHD finger protein to coactivate transcription

Schneider, T.L.; Schepartz, A., 2001:
Hepatitis B virus protein pX enhances the monomer assembly pathway of bZIPcntdotDNA complexes

Yeo, W.; Chan, P.K.S.; Chan, H.L.Y.; Mo, F.K.F.; Johnson, P.J., 2001:
Hepatitis B virus reactivation during cytotoxic chemotherapy-enhanced viral replication precedes overt hepatitis

Sakamaki, H.; Sato, Y.; Mori, S.I.hiro; Ohashi, K.; Tanikawa, S.; Akiyama, H.; Sasaki, T.; Hiruma, K., 2001:
Hepatitis B virus reactivation in a patient with chronic GVHD after allogeneic peripheral blood stem cell transplantation

Yeo, W.; Chan, P.K.S.; Hui, P.; Ho, W.M.; Lam, K.C.; Kwan, W.H.; Zhong, S.; Johnson, P.J., 2003:
Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study

Steinberg, J.L.; Yeo, W.; Zhong, S.; Chan, J.Y.H.; Tam, J.S.; Chan, P.K.S.; Leung, N.W.Y.; Johnson, P.J., 2000:
Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: Precore/core mutations may play an important role

Anjos, Lucio-Cortes-Dos, 2001:
Hepatitis B virus replication markers: Comparison of molecular biological, serological and immunohistochemical methods

Nassal, M., 1999:
Hepatitis B virus replication: novel roles for virus-host interactions

Alka, S.; Hemlata, D.; Vaishali, C.; Shahid, J.; Kumar, P.-Subrat, 2000:
Hepatitis B virus surface (S) transactivator with DNA-binding properties

Chen, W.N.; Oon, C.J., 2000:
Hepatitis B virus surface antigen (HBsAg) mutants in Singapore adults and vaccinated children with high anti-hepatitis B virus antibody levels but negative for HBsAg

Chen, W.Ning.; Oon, C.Jin.; Lim, G.Keow., 2002:
Hepatitis B virus surface antigen mutants persist in chronic carriers receiving lamivudine therapy in Singapore

Vanlandschoot, P.; Van Houtte, F.; Roobrouck, A.; Farhoudi, A.; Leroux-Roels, G., 2002:
Hepatitis B virus surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte-specific receptor

Teles, S.A.; Martins, R.M.B.; Gomes, S.A.; Gaspar, A.M.C.; Araujo, Nália.M.; Souza, K.P.; Carneiro, M.A.S.; Yoshida, C.F.T., 2002:
Hepatitis B virus transmission in Brazilian hemodialysis units: serological and molecular follow-up

Chlabicz, S.; Grzeszczuk, A., 2000:
Hepatitis B virus vaccine for patients with hepatitis C virus infection

Liu, C.J.; Chen, P.J.; Lai, M.Y.; Kao, J.H.; Chen, D.S., 2001:
Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequences

Oon, C.J.n; Chen, W.N.ng; Lim, N.; Koh, S.; Lim, G.K.ow; Leong, A.L.n; Tan, G.S.n, 1999:
Hepatitis B virus variants with lamivudine-related mutations in the DNA polymerase and the 'a' epitope of the surface antigen are sensitive to ganciclovir

Yoo, J.; Rho, J.; Lee, D.; Shin, S.; Jung, G., 2002:
Hepatitis B virus vector carries a foreign gene into liver cells in vitro

Park, U.S.n; Park, S.K.ung; Lee, Y.I.; Park, J.G.; Lee, Y.I., 2000:
Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1fwdarwS transition via a p53-independent pathway in human hepatoma cells

Beckebaum, S.; Cicinnati, V.R.; Zhang, X.; Ferencik, S.; Frilling, A.; Grosse Wilde, H.; Broelsch, C.E.ich; Gerken, G., 2003:
Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: Mechanisms for viral immune escape

Chomarat, P.; Rice, J.M.; Slagle, B.L.; Wild, C.P., 1998:
Hepatitis B virus-induced liver injury and altered expression of carcinogen metabolising enzymes: The role of the HBx protein

Norton, P.A.; Gong, Q.; Mehta, A.S.; Lu, X.; Block, T.M., 2003:
Hepatitis B virus-mediated changes of apolipoprotein mRNA abundance in cultured hepatoma cells

Livezey, K.W.; Negorev, D.; Simon, D., 2000:
Hepatitis B virus-transfected Hep G2 cells demonstrate genetic alterations and de novo viral integration in cells replicating HBV

Kim, Y.; Hong, Y.B.n; Jung, G., 1999:
Hepatitis B virus: DNA polymerase activity of deletion mutants

Rokuhara, A.; Kiyosawa, K., 2002:
Hepatitis B virus: Mutations in the precore/basal core promoter and viral replication

Karayiannis, P., 2003:
Hepatitis B virus: old, new and future approaches to antiviral treatment

Arankalle, V.A.; Murhekar, K.M.; Gandhe, S.S.; Murhekar, M.V.; Ramdasi, A.Y.; Padbidri, V.S.; Sehgal, S.C., 2003:
Hepatitis B virus: predominance of genotype D in primitive tribes of the Andaman and Nicobar islands, India (1989-1999)

Prost, S.; Ford, J.M.; Taylor, C.; Doig, J.; Harrison, D.J., 1998:
Hepatitis B x protein inhibits p53-dependent DNA repair in primary mouse hepatocytes

Miller, M.E.Y.; Pierre, R.B.; Plummer, M.H.; Shah, D.J., 2002:
Hepatitis B-associated nephrotic syndrome in Jamaican children

Balkaran, B.N.; Teelucksingh, S.; Singh, V.R., 2000:
Hepatitis B-associated polyarteritis nodosa and hypertensive encephalopathy

Guo, X.; Gopalan, R.; Ugbarugba, S.; Stringer, H.; Heisler, M.; Foreman, M.; Nzerue, C., 2001:
Hepatitis B-related polyarteritis nodosa complicated by pulmonary hemorrhage

Maddrey, Willis, C., 2000:
Hepatitis B: An important public health issue

Pirovino, M., 1998:
Hepatitis B: clinical manifestations, diagnosis and medical management

Cadranel, J.F.; Caron, C.; Collot, G.; Van Batten, C.; Dumouchel, P., 1999:
Hepatitis B: Epidemiology, natural history, laboratory findings, and treatment monitoring

Petinelli, E.V.; Sakgana, E.D., 2002:
Hepatitis B: Recent data concerning diagnosis and observation of the disease

Frei, P., C.; Grob, P., J., 1998:
Hepatitis B: Serological markers of diagnosis and follow-up

Schmid, J., 2000:
Hepatitis B: The neglected sexually transmitted disease

Van Damme, Pierre, 2001:
Hepatitis B: Vaccination programmes in Europe: An update

Grob, Peter, J., 1998:
Hepatitis B: Virus, pathogenesis and treatment

Butkiewicz, N.J.; Yao, N.; Wright-Minogue, J.; Zhang, R.; Ramanathan, L.; Lau, J.Y.; Hong, Z.; Dasmahapatra, B., 2000:
Hepatitis C NS3 protease: restoration of NS4A cofactor activity by N-biotinylation of mutated NS4A using synthetic peptides

Mchutchison, John, G., 2002:
Hepatitis C advances in antiviral therapy: What is accepted treatment now?

Chanpong, G.Fraser.; Laras, K.; Sulaiman, H.Ali.; Soeprapto, W.; Purnamawati, S.; Sukri, N.; Sie, A.; Tan, R.; Campbell, J.R.; Corwin, A.L., 2002:
Hepatitis C among child transfusion and adult renal dialysis patients in Indonesia

Des-Jarlais, D., C.; Schuchat, A., 2001:
Hepatitis C among drug users: Deja vu all over again?

Obermayer-Straub, P.; Manns, M.P., 2001:
Hepatitis C and D, retroviruses and autoimmune manifestations

Michaelis, S.; Kazakov, D.V.; Schmid, M.; Dummer, R.; Burg, G.; Kempf, W., 2003:
Hepatitis C and G viruses in B-cell lymphomas of the skin

Soriano, V.; Garcia-Samaniego, J.; Rodriguez-Rosado, R.; Gonzalez, J.; Pedreira, J., 1999:
Hepatitis C and HIV infection: Biological, clinical, and therapeutic implications

Mohsen, A.H.; Easterbrook, P.; Taylor, C.B.; Norris, S., 2002:
Hepatitis C and HIV-1 coinfection

Degos, Francoise, 1999:
Hepatitis C and alcohol

Morgan, T.R.; Brenner, D.; Everhart, J.; French, S.W.; Fried, M.W.; Gretch, D.R.; Koziel, M.J.mes; Mcclain, C.J.; Peters, M.G.; Weinman, S.A.; Lucas, D.L., 2003:
Hepatitis C and alcohol: Fundamental and translational research directions

Darwish, M.A.; Faris, R.; Darwish, N.; Shouman, A.; Gadallah, M.; El-Sharkawy, M.S.; Edelman, R.; Grumbach, K.; Rao, M.R.; Clemens, J.D., 2001:
Hepatitis c and cirrhotic liver disease in the Nile delta of Egypt: a community-based study

Forton, D.M.; Thomas, H.C.; Murphy, C.A.; Allsop, J.M.; Foster, G.R.; Main, J.; Wesnes, K.A.; Taylor-Robinson, S.D., 2002:
Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease

Busek, S.U.; Babá, E.H.; Tavares Filho, Hélcio.A.; Pimenta, Líno.; Salomão, Aão.; Corrêa-Oliveira, R.; Oliveira, G.C., 2002:
Hepatitis C and hepatitis B virus infection in different hemodialysis units in Belo Horizonte, Minas Gerais, Brazil

Coward, R.A.; Garrues, M.; Solomon, L.R.; Gibson, S.P., 2000:
Hepatitis C and holiday dialysis. A postal survey of UK renal units

Thomas, David, L., 2002:
Hepatitis C and human immunodeficiency virus infection

Olynyk, J.K., 1999:
Hepatitis C and iron

Curtis, John, J., 2000:
Hepatitis C and management of end-stage renal disease

Sulkowski, M.S.; Moore, R.D.; Mehta, S.H.; Chaisson, R.E.; Thomas, D.L., 2002:
Hepatitis C and progression of HIV disease

Carithers, Robert, L.Jr, 1999:
Hepatitis C and renal failure

Abbott, K.C.; Bucci, J.R.; Matsumoto, C.S.; Swanson, S.John.; Agodoa, L.Y.C.; Holtzmuller, K.C.; Cruess, D.F.; Peters, T.G., 2003 :
Hepatitis C and renal transplantation in the era of modern immunosuppression

Reindollar, Robert, W., 1999:
Hepatitis C and the correctional population

Widjaja, A.; Wedemeyer, H.; Tillmann, H.L.; Horn, R.; Ockenga, J.; Manns, M.P.; Von Zur Muehlen, A.; Brabant, G., 2001:
Hepatitis C and the leptin system: Bound leptin levels are elevated in patients with hepatitis C and decrease during antiviral therapy

Meier-Kriesche, H.U.; Ojo, A.O.; Hanson, J.A.; Kaplan, B., 2001:
Hepatitis C antibody status and outcomes in renal transplant recipients

Stein, M.D.; Maksad, J.; Clarke, J., 2001:
Hepatitis C disease among injection drug users: Knowledge, perceived risk and willingness to receive treatment

Bullock, G.C.; Bruns, D.E.; Haverstick, D.M., 2002:
Hepatitis C genotype determination by melting curve analysis with a single set of fluorescence resonance energy transfer probes

Shobokshi, O.A.; Serebour, F.E.; Skakni, L.; A.S.ffy, Y.H.; Ahdal, M.N., 1999:
Hepatitis C genotypes and subtypes in Saudi Arabia

Sanchez, J.L.; Sjogren, M.H.; Callahan, J.D.; Watts, D.M.; Lucas, C.; Abdel-Hamid, M.; Constantine, N.T.; Hyams, K.C.; Hinostroza, S.; Figueroa-Barrios, R.; Cuthie, J.C., 2001:
Hepatitis C in Peru: risk factors for infection, potential iatrogenic transmission, and genotype distribution

Medhat, A.; Shehata, M.; Magder, L.S.; Mikhail, N.; Abdel-Baki, L.; Nafeh, M.; Abdel-Hamid, M.; Strickland, G.Thomas.; Fix, A.D., 2002:
Hepatitis c in a community in Upper Egypt: risk factors for infection

Desenclos, J.C.; Bourdiol-Razès, M.; Rolin, B.; Garandeau, P.; Ducos, J.; Bréchot, C.; Thiers, V., 2002 :
Hepatitis C in a ward for cystic fibrosis and diabetic patients: possible transmission by spring-loaded finger-stick devices for self-monitoring of capillary blood glucose

Fried, M.W.; Peter, J.; Hoots, K.; Gaglio, P.J.; Talbut, D.; Davis, P.Charleton.; Key, N.S.; White, G.C.; Lindblad, L.; Rickles, F.R.; Abshire, T.C., 2002:
Hepatitis C in adults and adolescents with hemophilia: a randomized, controlled trial of interferon alfa-2b and ribavirin

Weinstock, D., M.; Merrick, S.; Malak, S.-Abdel; Jacobs, J.; Sepkowitz, K., A., 1999:
Hepatitis C in an urban population infected with the human immunodeficiency virus

Hardikar, Winita, 2002:
Hepatitis C in childhood

Latt, N.C.; Spencer, J.D.; Beeby, P.J.; Mccaughan, G.W.; Saunders, J.B.; Collins, E.; Cossart, Y.E., 2000:
Hepatitis C in injecting drug-using women during and after pregnancy

McCarthy, J.J.; Flynn, N., 2001:
Hepatitis C in methadone maintenance patients: prevalence and public policy implications

Bonacini, M.; Puoti, M., 2000:
Hepatitis C in patients with human immunodeficiency virus infection: diagnosis, natural history, meta-analysis of sexual and vertical transmission, and therapeutic issues

Spaulding, A.; Greene, C.; Davidson, K.; Schneidermann, M.; Rich, J., 1999:
Hepatitis C in state correctional facilities

Staples, C.T.; Rimland, D.; Dudas, D., 1999:
Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival

Dalgard, O.; Jeansson, S.; Skaug, K.; Raknerud, N.; Bell, H., 2003 :
Hepatitis C in the general adult population of Oslo: Prevalence and clinical spectrum

Rosen, Hugo, R., 2002:
Hepatitis C in the liver transplant recipient: Current understanding and treatment

Khalili, M.; Behm, B.W., 2002:
Hepatitis C in the setting of HIV co-infection

Rischitelli, G.; McCauley, L.; Lambert, W.E.; Lasarev, M.; Mahoney, E., 2002:
Hepatitis C in urban and rural public safety workers

Roy, K.; Kennedy, C.; Bagg, J.; Cameron, S.; Hunter, I.; Taylor, M., 2003:
Hepatitis C infection among dental personnel in the West of Scotland, UK

Shawky, S.; Ghabrah, T.M.; Abalkhail, B.A.; Soliman, N.K., 1999:
Hepatitis C infection among drug addicts

Strickland, D.K.; Riely, C.A.; Patrick, C.C.; Jones-Wallace, D.; Boyett, J.M.; Waters, B.; Fleckenstein, J.F.; Dean, P.J.; Davila, R.; Caver, T.E.; Hudson, M.M., 2000:
Hepatitis C infection among survivors of childhood cancer

Fabrizi, F.; Poordad, F.Fred.; Martin, P., 2002:
Hepatitis C infection and the patient with end-stage renal disease

Wiley, T.E.; Brown, J.; Chan, J., 2002:
Hepatitis C infection in African Americans: Its natural history and histological progression

Maggi, G.; Armitano, S.; Brambilla, L.; Brenna, M.; Cairo, M.; Galvani, G.; Gola, D.; Komla Ebri, K.; Marmondi, E.; Perricone, G.; Posca, M.; Vegezzi, P.G.; Vergani, C.; D.L.o, G., 1999:
Hepatitis C infection in an Italian population not selected for risk factors

Molle, Z.L.; Baqi, N.; Gretch, D.; Hidalgo, G.; Tejani, A.; Rabinowitz, S.S., 2002:
Hepatitis C infection in children and adolescents with end-stage renal disease

Yamac, K.; Aydemir, S.; Ozturk, G.; Fen, T.; Senol, E., 2000:
Hepatitis C infection in lymphoma patients in a Turkish center

Butt, A.A., 2002:
Hepatitis C information on the world wide web

Goldman, M.; Long, A., 2000:
Hepatitis C lookback in Canada

Freeman, A.J.; Zekry, A.; Whybin, L.R.; Harvey, C.E.; van Beek, I.A.; de Kantzow, S.L.; Rawlinson, W.D.; Boughton, C.R.; Robertson, P.W.; Marinos, G.; Lloyd, A.R., 2000:
Hepatitis C prevalence among Australian injecting drug users in the 1970s and profiles of virus genotypes in the 1970s and 1990s

Carneiro, M.A.; Martins, R.M.; Teles, S.A.; Silva, S.A.; Lopes, C.L.; Cardoso, D.D.; Vanderborght, B.O.; Yoshida, C.F., 2001:
Hepatitis C prevalence and risk factors in hemodialysis patients in Central Brazil: a survey by polymerase chain reaction and serological methods

Sandhu, J.; Preiksaitis, J.K.; Campbell, P.M.; Carriere, K.C.; Hessel, P.A., 1999:
Hepatitis C prevalence and risk factors in the northern Alberta dialysis population

Alavian, S.M.ayed; Gholami, B.; Masarrat, S., 2002:
Hepatitis C risk factors in Iranian volunteer blood donors: A case-control study

Upfal, M.J.; Naylor, P.; Mutchnick, M.M., 2001:
Hepatitis C screening and prevalence among urban public safety workers

Romanowski, B.; Preiksaitis, J.; Campbell, P.; Fenton, J., 2003:
Hepatitis C seroprevalence and risk behaviors in patients attending sexually transmitted disease clinics

Mchutchison, John, 1999:
Hepatitis C therapy in treatment-naive patients

Pfau, P.R.; Rho, R.; Denofrio, D.; Loh, E.; Blumberg, E.A.; Acker, M.A.; Lucey, M.R., 2000:
Hepatitis C transmission and infection by orthotopic heart transplantation

Wang, W.; Preville, P.; Morin, N.; Mounir, S.; Cai, W.; Siddiqui, M.A.shad, 2000:
Hepatitis C viral IRES inhibition by phenazine and phenazine-like molecules

Shi, S.T.; Lai, M.M.C., 2001:
Hepatitis C viral RNA: Challenges and promises

Hwang, S.J.ng; Lee, S.D.ng; Lu, R.H.a; Chu, C.W.i; Wu, J.C.ing; Lai, S.T.ng; Chang, F.Y.ung, 2001:
Hepatitis C viral genotype influences the clinical outcome of patients with acute posttransfusion hepatitis C

Markowitz, G.S.; Cheng, J.T.; Colvin, R.B.; Trebbin, W.M.; D'Agati, V.D., 1998:
Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy

Bekkering, F.C.; Brouwer, J.T.; Hansen, B.E.; Schalm, S.W., 2001:
Hepatitis C viral kinetics in difficult to treat patients receiving high dose interferon and ribavirin

de Araujo, E.Stanislau.Affonso.; Cavalheiro, N.de.Paula.; Cubero Leitao, R.Maria.; Borges Tosta, R.Aparecida.; Barone, A.Alci., 2002:
Hepatitis C viral load does not predict disease outcome: going beyond numbers

Kalkeri, G.; Khalap, N.; Akhter, S.; Garry, R.F.; Fermin, C.D.; Dash, S., 2001:
Hepatitis C viral proteins affect cell viability and membrane permeability

Garcia, J.-Eduardo; Puentes, A.; Suarez, J.; Lopez, R.; Vera, R.; Rodriguez, L.-Eduardo; Ocampo, M.; Curtidor, H.; Guzman, F.; Urquiza, M.; Patarroyo, M.-Elkin, 2002:
Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells

Shirota, Y.; Luo, H.; Qin, W.; Kaneko, S.; Yamashita, T.; Kobayashi, K.; Murakami, S., 2002:
Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity

Rossini, A.; Artini, M.; Levrero, M.; Almerighi, C.; Massari, M.; Biasi, L.; Radaeli, E.; Cariani, E., 2001:
Hepatitis C virus (HCV) RNA determination after two weeks of induction interferon treatment is an accurate predictor of nonresponse: Comparison of two treatment schedules

Furusyo, N.; Hayashi, J.; Kashiwagi, K.; Nakashima, H.; Nabeshima, S.; Sawayama, Y.; Kinukawa, N.; Kashiwagi, S., 2002:
Hepatitis C virus (HCV) RNA level determined by second-generation branched-DNA probe assay as predictor of response to interferon treatment in patients with chronic HCV viremia

Prakash, O.; Mason, A.; Luftig, R.B.; Bautista, A.P., 2002:
Hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) infections in alcoholics

Piroth, L.; Bourgeois, C.; Dantin, S.; Waldner, A.; Grappin, M.; Portier, H.; Chavanet, P., 1999:
Hepatitis C virus (HCV) genotype does not appear to be a significant prognostic factor in HIV-HCV-coinfected patients

Perrone, A.; Deramo, M.T.; Spaccavento, F.; Santarcangelo, P.; Favoino, B.; Antonaci, S., 2001:
Hepatitis C virus (HCV) genotypes, human leucocyte antigen expression and monoclonal gammopathy prevalence during chronic HCV infection

Leone, F.; Zylberberg, H.; Squadrito, G.; Le-Guen, B.; Berthelot, P.; Pol, S.; Brechot, C., 1998:
Hepatitis C virus (HCV) hypervariable region 1 complexity does not correlate with severity of liver disease, HCV type, viral load or duration of infection

Fornasieri, A.; Bernasconi, P.; Ribero, M.L.; Sinico, R.A.; Fasola, M.; Zhou, J.; Portera, G.; Tagger, A.; Gibelli, A.; D'amico, G., 2000:
Hepatitis C virus (HCV) in lymphocyte subsets and in B lymphocytes expressing rheumatoid factor cross-reacting idiotype in type II mixed cryoglobulinaemia

Schmidt, W.N.; Stapleton, J.T.; LaBrecque, D.R.; Mitros, F.A.; Kirby, P.A.; Phillips, M.J.; Brashear, D.L., 2000:
Hepatitis C virus (HCV) infection and cryoglobulinemia: analysis of whole blood and plasma HCV-RNA concentrations and correlation with liver histology

Abdel-Aziz, F.; Habib, M.; Mohamed, M.K.; Abdel-Hamid, M.; Gamil, F.; Madkour, S.; Mikhail, N.N.; Thomas, D.; Fix, A.D.; Strickland, G.T.; Anwar, W.; Sallam, I., 2000:
Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence

Cramp, M.E.; Carucci, P.; Rossol, S.; Chokshi, S.; Maertens, G.; Williams, R.; Naoumov, N.V., 1999:
Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia

Wood, J.; Frederickson, R.M.; Fields, S.; Patel, A.H., 2001:
Hepatitis C virus 3'X region interacts with human ribosomal proteins

Durante Mangoni, E.; Forton, D.M.; Ruggiero, G.; Karayiannis, P., 2003:
Hepatitis C virus E2 and NS5A region variability during sequential treatment with two interferon-alpha preparations

Imbert, I.; Dimitrova, M.; Kien, Fçois.; Kieny, M.Paule.; Schuster, C., 2003:
Hepatitis C virus IRES efficiency is unaffected by the genomic RNA 3'NTR even in the presence of viral structural or non-structural proteins

Koev, G.; Duncan, R.F.; Lai, M.M.C., 2002:
Hepatitis C virus IRES-dependent translation is insensitive to an elF2alpha-independent mechanism of inhibition by interferon in hepatocyte cell lines

Locatelli, G.A.rora; Spadari, S.; Maga, G., 2002:
Hepatitis C virus NS3 ATPase/helicase: An ATP switch regulates the cooperativity among the different substrate binding sites

Lam, A.M.I.; Keeney, D.; Eckert, P.Q.; Frick, D.N., 2003:
Hepatitis C virus NS3 ATPases/helicases from different genotypes exhibit variations in enzymatic properties

Locatelli, G.A.; Gosselin, G.; Spadari, S.; Maga, G., 2001:
Hepatitis C virus NS3 NTPase/helicase: different stereoselectivity in nucleoside triphosphate utilisation suggests that NTPase and helicase activities are coupled by a nucleotide-dependent rate limiting step

Archer, S.J.; Camac, D.M.; Wu, Z.J.; Farrow, N.A.; Domaille, P.J.; Wasserman, Z.R.; Bukhtiyarova, M.; Rizzo, C.; Jagannathan, S.; Mersinger, L.J.; Kettner, C.A., 2002:
Hepatitis C virus NS3 protease requires its NS4A cofactor peptide for optimal binding of a boronic acid inhibitor as shown by NMR

Drouet, C.; Bouillet, L.; Csopaki, F.; Colomb, M.G., 1999:
Hepatitis C virus NS3 serine protease interacts with the serpin C1 inhibitor

Kato, J.; Kato, N.; Yoshida, H.; Ono Nita, S.K.oko; Shiratori, Y.; Omata, M., 2002:
Hepatitis C virus NS4A and NS4B proteins suppress translation in vivo

Chung, Y-Lin.; Sheu, M-Ling.; Yen, S-Hue., 2003:
Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma

Majumder, M.; Ghosh, A.K.; Steele, R.; Ray, R.; Ray, R.B., 2001:
Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner

Qadri, I.; Iwahashi, M.; Simon, F., 2002:
Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3

Paterson, M.; Laxton, C.D.; Thomas, H.C.; Ackrill, A.M.; Foster, G.R., 1999:
Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response

Kim, J.; Lee, D.; Choe, J., 1999:
Hepatitis C virus NS5A protein is phosphorylated by casein kinase II

Ghosh, A.K.; Steele, R.; Meyer, K.; Ray, R.; Ray, R.B., 1999:
Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth

Ghosh, A.K.; Majumder, M.; Steele, R.; Yaciuk, P.; Chrivia, J.; Ray, R.; Ray, R.B., 2000:
Hepatitis C virus NS5A protein modulates transcription through a novel cellular transcription factor SRCAP

Ghosh, A.K.; Majumder, M.; Steele, R.; Meyer, K.; Ray, R.; Ray, R.B., 2000:
Hepatitis C virus NS5A protein protects against TNF-alpha mediated apoptotic cell death

Tanaka, T.; Sugiyama, K.; Ikeda, M.; Naganuma, A.; Nozaki, A.; Saito, M.; Shimotohno, K.; Kato, N., 2000:
Hepatitis C virus NS5B RNA replicase specifically binds ribosomes

Lakina, E.I.; Kushch, A.A., 2002:
Hepatitis C virus RNA in patients with chronic hepatitis C

Balciuniene, L.; Carlsson, T.; Ambrozaitis, A.; Reichard, O.; Weiland, O., 2003:
Hepatitis C virus RNA levels during initial induction or standard interferon therapy: Influence of continued treatment on sustained response

Tu, H.; Gao, L.; Shi, S.T.; Taylor, D.R.; Yang, T.; Mircheff, A.K.; Wen, Y.; Gorbalenya, A.E.; Hwang, S.B.; Lai, M.M., 1999:
Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein

Pontisso, P.; Bellati, G.; Brunetto, M.; Chemello, L.; Colloredo, G.; Di Stefano, R.; Nicoletti, M.; Rumi, M.G.; Ruvoletto, M.G.; Soffredini, R.; Valenza, L.M.; Colucci, G., 1999:
Hepatitis C virus RNA profiles in chronically infected individuals: do they relate to disease activity?

Puoti, C.; Castellacci, R.; Bellis, L.; Montagnese, F.; Corvisieri, P.; Festuccia, F.; Mellozzi, M.; Villani, A.R., 2002:
Hepatitis C virus RNA quantitation in hepatic veins and peripheral blood in patients with liver cirrhosis: Evidence for low level intrahepatic hepatitis C virus replication in advanced liver disease

Frese, M.; Barth, K.; Kaul, A.; Lohmann, V.; Schwärzle, V.; Bartenschlager, R., 2003:
Hepatitis C virus RNA replication is resistant to tumour necrosis factor-alpha

Shi, S.T.; Lee, K-Jeong.; Aizaki, H.; Hwang, S.B.; Lai, M.M.C., 2003:
Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2

Hardy, R.W.; Marcotrigiano, J.; Blight, K.J.; Majors, J.E.; Rice, C.M., 2003:
Hepatitis C virus RNA synthesis in a cell-free system isolated from replicon-containing hepatoma cells

Maag, D.; Castro, C.; Hong, Z.; Cameron, C.E., 2001:
Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin

Germi, R.; Crance, J.M.; Garin, D.; Thelu, M.A.; Guimet, J.; Jouan, A.; Lortat-Jacob, H.; Zarski, J.P.; Drouet, E., 1999:
Hepatitis C virus adsorption step study on different cell lines

Goldberg, D.; Cameron, S.; Sharp, G.; Burns, S.; Scott, G.; Molyneaux, P.; Scoular, A.; Downie, A.; Taylor, A., 2001:
Hepatitis C virus among genitourinary clinic attenders in Scotland: unlinked anonymous testing

Mele, A.; Pulsoni, A.; Bianco, E.; Musto, P.; Szklo, A.; Sanpaolo, M.Grazia.; Iannitto, E.; D.R.nzo, A.; Martino, B.; Liso, V.; Andrizzi, C.; Pusterla, S.; Dore, F.; Maresca, M.; Rapicetta, M.; Marcucci, F.; Mandelli, F.; Franceschi, S., 2003:
Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study

Gutiérrez, J.; Rodríguez-Iglesias, M., 2000:
Hepatitis C virus and Epstein-Barr virus: dual infection or atypical antibody response

Oubiña, J.R.; Quarleri, J.F.; Sawicki, M.A.; Mathet, V.L.; Ruiz, V.; Schroder, T.; Méndez, M.; Parera, V.; Muramatsu, H.; Battle, A.; González Cappa, S.M.; Fainboim, H.A., 2001:
Hepatitis C virus and GBV-C/hepatitis G virus in Argentine patients with porphyria cutanea tarda

Balasubramanian, A.; Ganju, R.K.; Groopman, J.E., 2003:
Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes

Van-Der-Poel, Cees, L., 1999:
Hepatitis C virus and blood transfusion: Past and present risks

Matsumori, Akira, 2000:
Hepatitis C virus and cardiomyopathy

Fleming, C.A.; Craven, D.E.; Thornton, D.; Tumilty, S.; Nunes, D., 2002:
Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment

Piccolo, P.; Borg, L.; Lin, A.; Melia, D.; Ho, A.; Kreek, M.Jeanne., 2002:
Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment

Dieterich, Douglas, T., 1999:
Hepatitis C virus and human immunodeficiency virus: Clinical issues in coinfection

Santini, G.F.; Crovatto, M.; Giannini, F.; Bortolin, M.T.; Mazzaro, C.; Invernizzi, F., 1998:
Hepatitis C virus and immunoglobulin gene rearrangements: an early step in lymphomagenesis?

Taylor, D.R.; Shi, S.T.; Lai, M.M.C., 2000:
Hepatitis C virus and interferon resistance

Shustov, A.V.; Mishin, V.P.; Maksyutov, A.Z.; Kiselev, N.N.; Sakharova, Y.G.; Tolokonskaya, N.P.; Robertson, B.J.; Netesov, S.V., 2000:
Hepatitis C virus and its genotype markers in patients in Novosibirsk

Shimotohno, K.; Watashi, K.; Tsuchihara, K.; Fukuda, K.; Marusawa, H.; Hijikata, M., 2002:
Hepatitis C virus and its roles in cell proliferation

Chuang, T.Y.; Stitle, L.; Brashear, R.; Lewis, C., 1999:
Hepatitis C virus and lichen planus: A case-control study of 340 patients

Macdonald, M.A.; Wodak, A.D.; Dolan, K.A.; Van Beek, I.; Cunningham, P.H.; Kaldor, J.M., 2000:
Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997

Timurağlu, A.; Colak, D.; Oğünç, D.; Karadoğan, I.; Undar, L., 1999:
Hepatitis C virus association with non-Hodgkin's lymphoma

Liu, F.; Knight, G.B.; Agnello, V., 1999:
Hepatitis C virus but not GB virus C/hepatitis G virus has a role in type II cryoglobulinemia

Puoti, C.; Castellacci, R.; Montagnese, F., 2000:
Hepatitis C virus carriers with persistently normal aminotransferase levels: Healthy people or true patients?

Inoue, G.; Horiike, N.; Michitaka, K.; Onji, M., 2000:
Hepatitis C virus clearance is prominent in women in an endemic area

Sun, J.; Bodola, F.; Fan, X.; Irshad, H.; Soong, L.; Lemon, S.M.; Chan, T.S., 2001:
Hepatitis C virus core and envelope proteins do not suppress the host's ability to clear a hepatic viral infection

Dolganiuc, A.; Kodys, K.; Kopasz, A.; Marshall, C.; Do, T.; Romics, L.; Mandrekar, P.; Zapp, M.; Szabo, G., 2003:
Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation

Yang, S-Hwan.; Lee, C.Geun.; Lee, C.Woo.; Choi, E-Ju.; Yoon, S.Kew.; Ahn, K.Seog.; Sung, Y.Chul., 2002:
Hepatitis C virus core inhibits the Fas-mediated p38 mitogen activated kinase signaling pathway in hepatocytes

Tokita, H.; Kaufmann, G.R.; Matsubayashi, M.; Okuda, I.; Tanaka, T.; Harada, H.; Mukaide, M.; Suzuki, K.; Cooper, D.A., 2000:
Hepatitis C virus core mutations reduce the sensitivity of a fluorescence enzyme immunoassay

Tsutsumi, T.; Suzuki, T.; Moriya, K.; Shintani, Y.; Fujie, H.; Miyoshi, H.; Matsuura, Y.; Koike, K.; Miyamura, T., 2003:
Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice

Hayashi, J.; Aoki, H.; Kajino, K.; Moriyama, M.; Arakawa, Y.; Hino, O., 2000:
Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor alpha

Mamiya, N.; Worman, H.J., 1999:
Hepatitis C virus core protein binds to a DEAD box RNA helicase

Sabile, A.; Perlemuter, G.; Bono, F.; Kohara, K.; Demaugre, F.; Kohara, M.; Matsuura, Y.; Miyamura, T.; Bréchot, C.; Barba, G., 1999:
Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates

Hosui, A.; Ohkawa, K.; Ishida, H.; Sato, A.; Nakanishi, F.; Ueda, K.; Takehara, T.; Kasahara, A.; Sasaki, Y.; Hori, M.; Hayashi, N., 2003:
Hepatitis C virus core protein differently regulates the JAK-STAT signaling pathway under interleukin-6 and interferon-gamma stimuli

Dumoulin, F.L.; Von Dem Bussche, A.; Soehne, J.; Sauerbruch, T.; Spengler, U., 1999:
Hepatitis C virus core protein does not inhibit apoptosis in human hepatoma cells

You, L.R.; Chen, C.M.; Lee, Y.H., 1999:
Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha

Otsuka, M.; Kato, N.; Lan, K.; Yoshida, H.; Kato, J.; Goto, T.; Shiratori, Y.; Omata, M., 2000:
Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability

Fukuda, K.; Tsuchihara, K.; Hijikata, M.; Nishiguchi, S.; Kuroki, T.; Shimotohno, K., 2000:
Hepatitis C virus core protein enhances the activation of the transcription factor, Elk1, in response to mitogenic stimuli

Giannini, C.; Caini, P.; Giannelli, F.; Fontana, F.; Kremsdorf, D.; Bréchot, C.; Zignego, A.Linda., 2002:
Hepatitis C virus core protein expression in human B-cell lines does not significantly modify main proliferative and apoptosis pathways

Wu, C.L.ang; Leu, T.S.iann; Chang, T.T.ung; Shiau, A.L., 1999:
Hepatitis C virus core protein fused to hepatitis B virus core antigen for serological diagnosis of both hepatitis C and hepatitis B infections by ELISA

Honda, M.; Kaneko, S.; Shimazaki, T.; Matsushita, E.; Kobayashi, K.; Ping, L.H.; Zhang, H.C.; Lemon, S.M., 2000:
Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells

Marusawa, H.; Hijikata, M.; Chiba, T.; Shimotohno, K., 1999:
Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation

Aoki, H.; Hayashi, J.; Moriyama, M.; Arakawa, Y.; Hino, O., 2000:
Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1

Owsianka, A.M.; Patel, A.H., 1999:
Hepatitis C virus core protein interacts with a human DEAD box protein DDX3

You, L.R.; Chen, C.M.; Yeh, T.S.; Tsai, T.Y.; Mai, R.T.; Lin, C.H.; Lee, Y.H., 1999:
Hepatitis C virus core protein interacts with cellular putative RNA helicase

Basu, A.; Meyer, K.; Ray, R.B.; Ray, R., 2002:
Hepatitis C virus core protein is necessary for the maintenance of immortalized human hepatocytes

Soguero, C.; Joo, M.; Chianese-Bullock, K.A.; Nguyen, D.Tony.; Tung, K.; Hahn, Y.S., 2002:
Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model

Chung, Y.M.; Park, K.J.; Choi, S.Y.; Hwang, S.B.; Lee, S.Y., 2001:
Hepatitis C virus core protein potentiates TNF-alpha-induced NF-kappaB activation through TRAF2-IKKbeta-dependent pathway

Park, K.J.n; Choi, S.H.; Koh, M.S.o; Kim, D.J.on; Yie, S.W.n; Lee, S.Y.ung; Hwang, S.B., 2001:
Hepatitis C virus core protein potentiates c-Jun N-terminal kinase activation through a signaling complex involving TRADD and TRAF2

Cho, J.W.; Baek, W.K.; Suh, S.I.; Yang, S.H.an; Chang, J.; Sung, Y.C.ul; Suh, M.H., 2001:
Hepatitis C virus core protein promotes cell proliferation through the upregulation of cyclin E expression levels

Tsuchihara, K.; Hijikata, M.; Fukuda, K.; Kuroki, T.; Yamamoto, N.; Shimotohno, K., 1999:
Hepatitis C virus core protein regulates cell growth and signal transduction pathway transmitting growth stimuli

Lee, M.Nam.; Jung, E.Young.; Kwun, H.Jin.; Jun, H.Ki.; Yu, D-Yeul.; Choi, Y.Hyun.; Jang, K.Lib., 2002:
Hepatitis C virus core protein represses the p21 promoter through inhibition of a TGF-beta pathway

Jin, D.Y.; Wang, H.L.; Zhou, Y.; Chun, A.C.; Kibler, K.V.; Hou, Y.D.; Kung, H.; Jeang, K.T., 2000:
Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation

Ray, R.B.; Ray, R., 2001:
Hepatitis C virus core protein: intriguing properties and functional relevance

Wodarz, Dominik, 2003:
Hepatitis C virus dynamics and pathology: The role of CTL and antibody responses

Taylor, D.R.; Tian, B.; Romano, P.R.; Hinnebusch, A.G.; Lai, M.M.; Mathews, M.B., 2001:
Hepatitis C virus envelope protein E2 does not inhibit PKR by simple competition with autophosphorylation sites in the RNA-binding domain

Gruener, N.H.; Jung, M.C.ristina; Ulsenheimer, A.; Gerlach, T.J.; Diepolder, H.M.; Schirren, C.A.; Hoffmann, R.; Waechtler, M.; Backmund, M.; Pape, G.R., 2002:
Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response

Salemi, M.; Vandamme, A-Mieke., 2001:
Hepatitis C virus evolutionary patterns studied through analysis of full-genome sequences

Neau, D.; Jouvencel, A-Christine.; Legrand, E.; Trimoulet, P.; Galperine, T.; Chitty, I.; Ventura, M.; Le Bail, B.; Morlat, P.; Lacut, J-Yves.; Ragnaud, J-Marie.; Dupon, M.; Fleury, Hé.; Lafon, M-Edith., 2003:
Hepatitis C virus genetic variability in 52 human immunodeficiency virus-coinfected patients

Liu, Z-Xu.; Nishida, H.; He, J-Wen.; Lai, M.M.C.; Feng, N.; Dennert, G., 2002:
Hepatitis C virus genotype 1b core protein does not exert immunomodulatory effects on virus-induced cellular immunity

Kumar, D.; Farrell, G.C.; Fung, C.; George, J., 2002:
Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response

Karino, Y.; Toyota, J.; Sugawara, M.; Miyazaki, K.; Kuwata, Y.; Yamazaki, K.; Sato, T.; Ohmura, T.; Matsushima, T., 2003:
Hepatitis C virus genotypes and hepatic fibrosis regulate 24-h decline of serum hepatitis C virus RNA during interferon therapy in patients with chronic hepatitis C

Costes, V.; Durand, L.; Pageaux, G.P.; Ducos, J.; Mondain, A.M.; Picot, M.C.; Domergue, J.; Larrey, D.; Baldet, P., 1999:
Hepatitis C virus genotypes and quantification of serum hepatitis C RNA in liver transplant recipients. Relationship with histologic outcome of recurrent hepatitis C

Davis, Gary, L., 1999:
Hepatitis C virus genotypes and quasispecies

Osella, A.R.; Misciagna, G.; Guerra, V.; Elba, S.; Buongiorno, G.; Cavallini, A.; Di Leo, A.; Sonzogni, L.; Mondelli, M.U.; Silini, E.M., 2001:
Hepatitis C virus genotypes and risk of cirrhosis in southern Italy

Reid, A.E.; Koziel, M.J.mes; Aiza, I.; Jeffers, L.; Reddy, R.; Schiff, E.; Lau, J.Y.N.; Dienstag, J.L.; Liang, T.J.ke, 1999:
Hepatitis C virus genotypes and viremia and hepatocellular carcinoma in the United States

Re, V.; Lampe, E.; Yoshida, C.-Fumiko; Mendes-De-Oliveira, J.; Lewis-Ximenez, L.; Spinsanti, L.; Elbarcha, O.; Contigiani, M., 2003:
Hepatitis C virus genotypes in Cordoba, Argentina. Unexpected high prevalence of genotype 2

Zusinaite, E.; Krispin, T.; Raukas, E.; Kiiver, K.; Salupere, R.; Ott, K.; Ustina, V.; Zilmer, K.; Schmidt, J.; Sizemski, L.; Jaago, K.; Luman, M.; Ilmoja, M.; Prukk, T.; Ustav, M., 2000:
Hepatitis C virus genotypes in Estonia

Silva, L.K.; Paraná, R.; Souza, S.P.; Berby, F.; Kay, A.; Trepó, C.; Santana, N.; Cotrim, H.; Lyra, L.G.; Reis, M.G., 2000:
Hepatitis C virus genotypes in a northeastern area of Brazil

Oliveira, G.C.; Carmo, R.A.; Rocha, M.O.C.; Silva, M.O.; Lima, A.T.; Guimaraes, M.D.C.; Correa Oliveira, R., 1999:
Hepatitis C virus genotypes in hemophiliacs in the state of Minas Gerais, Brazil

Halfon, P.; Trimoulet, P.; Bourliere, M.; Khiri, H.; de Lédinghen, V.; Couzigou, P.; Feryn, J.M.; Alcaraz, P.; Renou, C.; Fleury, H.J.; Ouzan, D., 2001:
Hepatitis C virus genotyping based on 5' noncoding sequence analysis (Trugene)

Roca, J.; Ahmad, M.; Panda, S.K.mar; Padron, G.; Jameel, S., 1999:
Hepatitis C virus genotyping in developing countries: Results from Cuba, India and Turkey

Zekri, A.R.; Bahnassy, A.A.; Shaarawy, S.M.; Mansour, O.A.; Maduar, M.A.; Khaled, H.M.; El-Ahmadi, O., 2000:
Hepatitis C virus genotyping in relation to neu-oncoprotein overexpression and the development of hepatocellular carcinoma

Zekri, A.R.N.; Bahnassy, A.A.; Ramadan, A.S.; E.B.ssuoni, M.; Badran, A.; Madwar, M.A., 2001:
Hepatitis C virus genotyping versus serotyping in Egyptian patients

Duvet, S.; Cocquerel, L.; Pillez, A.; Cacan, R.; Verbert, A.; Moradpour, D.; Wychowski, C.; Dubuisson, J., 1998:
Hepatitis C virus glycoprotein complex localization in the endoplasmic reticulum involves a determinant for retention and not retrieval

Pöhlmann, S.; Zhang, J.; Baribaud, Fédéric.; Chen, Z.; Leslie, G.J.; Lin, G.; Granelli-Piperno, A.; Doms, R.W.; Rice, C.M.; McKeating, J.A., 2003:
Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR

Lukina, E.A.; Sysoeva, E.P.; Guschin, A.E.; Pavlov, C.S.; Tsvetaeva, N.V.; Filatov, F.P.; Khoroshko, N.D.; Frank, G.A.; Ivashkin, V.T., 2000:
Hepatitis C virus in bone marrow and blood cells of patients with obscure hematological syndromes

Laskus, T.; Radkowski, M.; Piasek, A.; Nowicki, M.; Horban, A.; Cianciara, J.; Rakela, J., 2000:
Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes

Gonçales, F.L.; Stucchi, R.S.; Pavan, M.H.; Angerami, R.N.; Gonçales, N.S., 2000:
Hepatitis C virus in monozygotic twins

Pioltelli, P.; Gargantini, L.; Cassi, E.; Santoleri, L.; Bellati, G.; Magliano, E.M.ssimo; Morra, E., 2000:
Hepatitis C virus in non-Hodgkin's lymphoma. A reappraisal after a prospective case-control study of 300 patients

Rivanera, D.; Lilli, D.; Griso, D.; Macrì, A.; Mancini, C., 1998:
Hepatitis C virus in patients with porphyria cutanea tarda: relationship to HCV-genotypes

Radkowski, M.; Wang, L.F.; Vargas, H.; Rakela, J.; Laskus, T., 1999:
Hepatitis C virus in peripheral blood mononuclear cells from a chronically infected patient receiving liver graft from infected donor

Hardy, N.M.; Chiao, J.; Arora, N.; Mars, R.; Jenkins, S.G., 2000:
Hepatitis C virus in the hemodialysis setting: detecting viral RNA from blood port caps by reverse transcription-polymerase chain reaction

Serfaty, L.; Andreani, T.; Giral, P.; Carbonell, N.; Chazouilleres, O.; Poupon, R., 2001:
Hepatitis C virus induced hypobetalipoproteinemia: A possible mechanism for steatosis in chronic hepatitis C

Carmo, R.A.; Oliveira, G.C.; Guimarães, M.D.C.; Oliveira, M.S.; Lima, A.A.; Buzek, S.C.; Corrêa-Oliveira, R.; Rocha, M.O.C., 2002:
Hepatitis C virus infection among Brazilian hemophiliacs: a virological, clinical and epidemiological study

Koblin, B.A.; Factor, S.H.; Wu, Y.; Vlahov, D., 2003:
Hepatitis C virus infection among noninjecting drug users in New York City

Njouom, R.; Pasquier, C.; Ayouba, A.; Sandres-Sauné, K.; Mfoupouendoun, J.; Mony Lobe, M.; Tene, G.; Thonnon, J.; Izopet, J.; Nerrienet, E., 2003:
Hepatitis C virus infection among pregnant women in Yaounde, Cameroon: prevalence, viremia, and genotypes

Chang, C.J.n; Lin, C.H.i; Lee, C.T.; Chang, S.J.n; Ko, Y.C.in; Liu, H.W.n, 1999:
Hepatitis C virus infection among short-term intravenous drug users in southern Taiwan

Huang, J.F.; Lu, S.N.; Chue, P.Y.; Lee, C.M.; Yu, M.L.; Chuang, W.L.; Wang, J.H.; Dai, C.Y.; Chen, I.L.; Shih, C.H.; Chang, W.Y., 2001:
Hepatitis C virus infection among teenagers in an endemic township in Taiwan: Epidemiological and clinical follow-up studies

Maio, G.; D'argenio, P.; Stroffolini, T.; Bozza, A.; Sacco, L.; Tosti, M.E.ena; Intorcia, M.; Fossi, E.; D'alessio, G.; Kondili, L.A.esti; Rapicetta, M.; Mele, A.; Collaborating Group, 2000:
Hepatitis C virus infection and alanine transaminase levels in the general population: A survey in a southern Italian town

Strasser, S.I.; Myerson, D.; Spurgeon, C.L.; Sullivan, K.M.; Storer, B.; Schoch, H.G.; Kim, S.; Flowers, M.E.; McDonald, G.B., 1999:
Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up

Pradier, C.; Carrieri, M.P.; Piche, M.; Rosenthal, E.; Dellamonica, P.; Serraino, D., 2003:
Hepatitis C virus infection and cancer risk among HIV-infected individuals

Sekine, I.; Dobashi, H.; Kogawa, K.; Hirota, T.; Katano, N.; Kawakami, K.; Koizumi, S.; Hyakuna, N.; Nakayama, M.; Takaue, Y.; Yamamura, Y.; Furuyama, T.; Kenichi; Nishikawa; Ohta, S.; Kubota, H.; Mimaya, J.; Horikoshi, Y.; Tsuchiya, T., 1998:
Hepatitis C virus infection and chronic liver diseases after treatment of malignant disease in children: A multicenter study from the Children's Cancer and Leukemia Study Group of Japan

Ndjomou, J.; Kupfer, B.; Kochan, B.; Zekeng, L.; Kaptue, L.; Matz, B., 2002:
Hepatitis C virus infection and genotypes among human immunodeficiency virus high-risk groups in Cameroon

Mehta, S.H.; Brancati, F.L.; Strathdee, S.A.; Pankow, J.S.; Netski, D.; Coresh, J.; Szklo, M.; Thomas, D.L., 2003:
Hepatitis C virus infection and incident type 2 diabetes

Cotler, S.J.; Jensen, D.M.; Kesten, S., 1999:
Hepatitis C virus infection and lung transplantation: A survey of practices

Hausfater, P.; Cacoub, P.; Rosenthal, E.; Bernard, N.; Loustaud Ratti, V.; L.L.stec, Z.; Laurichesse, H.; Turpin, F.; Ouzan, D.; Grasset, D.; Perrone, C.; Cabrol, M.P.; Piette, J.C., 2000:
Hepatitis C virus infection and lymphoproliferative diseases in France: A national study

Hausfater, P.; Cacoub, P.; Sterkers, Y.; Thibault, V.; Amoura, Z.; Nguyen, L.; Ghillani, P.; Leblond, V.; Piette, J.C., 2001:
Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France

Villanova, M.; Caudai, C.; Sabatelli, P.; Toti, P.; Malandrini, A.; Luzi, P.; Maraldi, N.M.; Valensin, P.E.; Merlini, L., 2000:
Hepatitis C virus infection and myositis: A polymerase chain reaction study

Hahn, J.A.; Page-Shafer, K.; Lum, P.J.; Ochoa, K.; Moss, A.R., 2001:
Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco

Van Der Meij, E.H.; Van Der Waal, I., 2000:
Hepatitis C virus infection and oral lichen planus: A report from the Netherlands

Sulkowski, M.S.; Mast, E.E.; Seeff, L.B.; Thomas, D.L., 2000:
Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus

Bortolotti, F.; Muratori, L.; Jara, P.; Hierro, L.; Verucchi, G.; Giacchino, R.; Barbera, C.; Zancan, L.; Guido, M.; Resti, M.; Pedditzi, S.; Bianchi, F.; Gatta, A., 2003:
Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children

Hershow, R.C.; Kalish, L.A.; Sha, B.; Till, M.; Cohen, M., 1998:
Hepatitis C virus infection in Chicago women with or at risk for HIV infection: evidence for sexual transmission

Naoumov, Nikolai, V., 1999:
Hepatitis C virus infection in Eastern Europe

Salama, G.; Rostaing, L.; Sandres, K.; Izopet, J., 2000:
Hepatitis C virus infection in French hemodialysis units: A multicenter study

Bdour, S., 2002:
Hepatitis C virus infection in Jordanian haemodialysis units: serological diagnosis and genotyping

Trepo, C.; Pradat, P., 1999:
Hepatitis C virus infection in Western Europe

Torres, M.C.M.R.; Pereira, L.M.M.B.; Ximenes, R.A.A.; Araújo, A.S.; Secaf, M.; Rodrigues, S.S.; Bezerra, A.C.S.; Conceição, I.B.; Valença, M.I.B.; Martinelli, A.L.C., 2003:
Hepatitis C virus infection in a Brazilian population with sickle-cell anemia

Habib, M.; Mohamed, M.K.; Abdel-Aziz, F.; Magder, L.S.; Abdel-Hamid, M.; Gamil, F.; Madkour, S.; Mikhail, N.N.; Anwar, W.; Strickland, G.T.; Fix, A.D.; Sallam, I., 2000:
Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity

Silini, E.; Locasciulli, A.; Santoleri, L.; Gargantini, L.; Pinzello, G.; Montillo, M.; Foti, L.; Lisa, A.; Orfeo, N.; Magliano, E.; Nosari, A.; Morra, E., 2002:
Hepatitis C virus infection in a hematology ward: evidence for nosocomial transmission and impact on hematologic disease outcome

Nakamura, K.; Matsumori, A.; Kusano, K.F.; Banba, K.; Taniyama, M.; Nakamura, Y.; Morita, H.; Matsubara, H.; Yamanari, H.; Ohe, T., 2000:
Hepatitis C virus infection in a patient with dermatomyositis and left ventricular dysfunction

Ruiz-Moreno, M.; Leal-Orozco, A.; Millan, A., 1999:
Hepatitis C virus infection in children

Pereira, Brian, J.G., 1999:
Hepatitis C virus infection in dialysis: A continuing problem

Sermoneta-Gertel, S.; Donchin, M.; Adler, R.; Baras, M.; Perlstein, T.; Manny, N.; Shouval, D.; Galun, E., 2002:
Hepatitis c virus infection in employees of a large university hospital in Israel

Scotto, G.; Avcella, F.; Panunzio, M.; Savastano, A.M.; Ktena, M.; Forcella, M.; Fazio, V.; Calzone, G.; Passione, A.; Procaccini, D.; Demin, A.; Stallone, C., 1999:
Hepatitis C virus infection in four haemodialysis units of southern Italy: Epidemiological report

Moraes, Cleusa-Regina-De, 2001:
Hepatitis C virus infection in hemodialysis patients and workers. A case-control study in Santa Catarina State dialysis units

Backmund, M.; Meyer, K.; Waechtler, M.; Eichenlaub, D., 2003:
Hepatitis C virus infection in injection drug users in Bavaria: Risk factors for seropositivity

Sawayama, Y.; Hayashi, J.; Kakuda, K.; Furusyo, N.; Ariyama, I.; Kawakami, Y.; Kinukawa, N.; Kashiwagi, S., 2000:
Hepatitis C virus infection in institutionalized psychiatric patients: possible role of transmission by razor sharing

Mizorogi, F.; Hiramoto, J.; Nozato, A.; Takekuma, Y.; Nagayama, K.; Tanaka, T.; Takagi, K., 2000:
Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma

Gharagozloo, S.; Khoshnoodi, J.; Shokri, F., 2001:
Hepatitis C virus infection in patients with essential mixed cryoglobulinemia, multiple myeloma and chronic lymphocytic leukemia

Germanidis, G.; Haioun, C.; Pourquier, J.; Gaulard, P.; Pawlotsky, J.M.; Dhumeaux, D.; Reyes, F., 1999:
Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center

Zoulim, Fabien, 1999:
Hepatitis C virus infection in special groups

Stroffolini, T.; Lorenzoni, U.; Menniti Ippolito, F.; Infantolino, D.; Chiaramonte, M., 2001:
Hepatitis C virus infection in spouses: Sexual transmission or common exposure to the same risk factors?

Alter, Miriam, J., 1999:
Hepatitis C virus infection in the United States

Chowdhury, A.; Santra, A.; Chaudhuri, S.; Dhali, G.Krishna.; Chaudhuri, S.; Maity, S.Gopal.; Naik, T.Nath.; Bhattacharya, S.Kumar.; Mazumder, D.Nath.Guha., 2003:
Hepatitis C virus infection in the general population: a community-based study in West Bengal, India

First, M.Roy, 2000:
Hepatitis C virus infection in the renal transplant recipient

Locatelli, A.; Roncaglia, N.; Arreghini, A.; Bellini, P.; Vergani, P.; Ghidini, A., 1999:
Hepatitis C virus infection is associated with a higher incidence of cholestasis of pregnancy

Ramos-Casals, M.; Font, J.; García-Carrasco, M.; Cervera, R.; Jiménez, S.; Trejo, O.; de la Red, G.; Sánchez-Tapias, J.M.; Ingelmo, M., 2001:
Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus

Bonetti, B.; Scardoni, M.; Monaco, S.; Rizzuto, N.; Scarpa, A., 1999:
Hepatitis C virus infection of peripheral nerves in type II cryoglobulinaemia

Ren, F.; Hino, K.; Yamaguchi, Y.; Okazaki, M.; Kitase, A.; Satoh, Y.; Korenaga, M.; Okuda, M.; Okita, K., 2003:
Hepatitis C virus infection upregulates expression of the type I interferon receptor in human peripheral blood mononuclear cells

Mercié, P.; Viallard, J.F.; Faure, I.; Trimoulet, P.; Vital, A.; Lifermann, F.; Leng, B.; Pellegrin, J.L., 2000:
Hepatitis C virus infection with and without cryoglobulinemia as a case of Churg-Strauss syndrome

Lidove, O.; Cacoub, P.; Maisonobe, T.; Servan, J.; Thibault, V.; Piette, J.C.; Leger, J.M., 2001:
Hepatitis C virus infection with peripheral neuropathy is not always associated with cryoglobulinaemia

Monga, H.K.; Rodriguez-Barradas, M.C.; Breaux, K.; Khattak, K.; Troisi, C.L.; Velez, M.; Yoffe, B., 2001:
Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection

Mastromatteo, A.M.; Rapaccini, G.L.; Pompili, M.; Ursino, S.; Romano-Spica, V.; Gasbarrini, G.; Vanini, G., 2001:
Hepatitis C virus infection: other biological fluids than blood may be responsible for intrafamilial spread

Par, A.; Gervain, J.; Gogl, A., 1998:
Hepatitis C virus infection: Pathogenesis, diagnosis and treatment

Taglione, E.; Vatteroni, M.L.; Martini, P.; Galluzzo, E.; Lombardini, F.; Delle Sedie, A.; Bendinelli, M.; Pasero, G.; Bencivelli, W.; Riente, L., 1999:
Hepatitis C virus infection: prevalence in psoriasis and psoriatic arthritis

Thorpe, L.E.; Ouellet, L.J.; Levy, J.R.; Williams, I.T.; Monterroso, E.R., 2000:
Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999

Foster, G.R., 1999:
Hepatitis C virus infection: Quality of life and side effects of treatment

Racanelli, V.; Rehermann, B., 2003:
Hepatitis C virus infection: When silence is deception

Jubin, R.; Vantuno, N.E.; Kieft, J.S.; Murray, M.G.; Doudna, J.A.; Lau, J.Y.; Baroudy, B.M., 2000:
Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES folding

Lyons, A.J.; Lytle, J.R.; Gomez, J.; Robertson, H.D., 2001:
Hepatitis C virus internal ribosome entry site RNA contains a tertiary structural element in a functional domain of stem-loop II

Pudi, R.; Abhiman, S.; Srinivasan, N.; Das, S., 2003:
Hepatitis C virus internal ribosome entry site-mediated translation is stimulated by specific interaction of independent regions of human La autoantigen

Rosa, H.; Martins, R.; Vanderborght, B., 2000:
Hepatitis C virus investigation in Pemphigus foliaceus (fogo selvagem) patients

Lesens, O.; Deschênes, M.; Steben, M.; Bélanger, G.; Tsoukas, C.M., 1999:
Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection

Garcia-Retortillo, M.; Forns, X.; Feliu, A.; Moitinho, E.; Costa, J.; Navasa, M.; Rimola, A.; Rodes, J., 2002:
Hepatitis C virus kinetics during and immediately after liver transplantation

Forns, X.; Thimme, R.; Govindarajan, S.; Emerson, S.U.; Purcell, R.H.; Chisari, F.V.; Bukh, J., 2000:
Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees

Daar, E.S.; Lynn, H.; Donfield, S.; Gomperts, E.; O'Brien, S.J.; Hilgartner, M.W.; Hoots, W.K.; Chernoff, D.; Arkin, S.; Wong, W.Y.; Winkler, C.A., 2001:
Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs

Kurbanov, F.; Tanaka, Y.; Sugauchi, F.; Kato, H.; Ruzibakiev, R.; Zalyalieva, M.; Yunusova, Z.; Mizokami, M., 2003:
Hepatitis C virus molecular epidemiology in Uzbekistan

Sarrazin, C.; Herrmann, E.; Bruch, K.; Zeuzem, S., 2002:
Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analyses

Polyak, S.J.; Khabar, K.S.; Paschal, D.M.; Ezelle, H.J.; Duverlie, G.; Barber, G.N.; Levy, D.E.; Mukaida, N.; Gretch, D.R., 2001:
Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response

Feng, D.; Cheng, R.; Ouyang, X.; Zheng, H.; Tsutomu, T., 2002:
Hepatitis C virus nonstructural protein NS(3) and telomerase activity

Iwai, A.; Hasumura, Y.; Nojima, T.; Takegami, T., 2003:
Hepatitis C virus nonstructural protein NS3 binds to Sm-D1, a small nuclear ribonucleoprotein associated with autoimmune disease

Park, J.S.; Yang, J.M.; Min, M.K., 2000:
Hepatitis C virus nonstructural protein NS4B transforms NIH3T3 cells in cooperation with the Ha-ras oncogene

Mottola, G.; Cardinali, G.; Ceccacci, A.; Trozzi, C.; Bartholomew, L.; Torrisi, M.Rosaria.; Pedrazzini, E.; Bonatti, S.; Migliaccio, G., 2002:
Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons

Pumeechockchai, W.; Bevitt, D.; Agarwal, K.; Petropoulou, T.; Langer, B.C.A.; Belohradsky, B.; Bassendine, M.F.; Toms, G.L., 2002:
Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: Implications for virus clearance by antibody

Souto, F.J.; Fontes, C.J.; Martelli, C.M.; Turchi, M.D.; Martins, R.M.; Andrade, A.L., 1999:
Hepatitis C virus prevalence among an immigrant community to the southern Amazon, Brazil

Sherman, K.E.; Rouster, S.D.; Chung, R.T.; Rajicic, N., 2002:
Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group

Alam, S.S.; Nakamura, T.; Naganuma, A.; Nozaki, A.; Nouso, K.; Shimomura, H.; Kato, N., 2002:
Hepatitis C virus quasispecies in cancerous and noncancerous hepatic lesions: the core protein-encoding region

Bizollon, T.; Ducerf, C.; Trepo, C.; Mutimer, D., 1999:
Hepatitis C virus recurrence after liver transplantation

Degos, F.; Christidis, C.; Ganne Carrie, N.; Farmachidi, J.P.; Degott, C.; Guettier, C.; Trinchet, J.C.; Beaugrand, M.; Chevret, S., 2000:
Hepatitis C virus related cirrhosis: Time to occurrence of hepatocellular carcinoma and death

Ortiz-Movilla, N.; Lázaro, P.; Rodríguez-Iñigo, E.; Bartolomé, J.; Longo, I.; Lecona, M.; Pardo, M.; Carreño, V., 2002:
Hepatitis C virus replicates in sweat glands and is released into sweat in patients with chronic hepatitis C

Kohara, Michinori, 2000:
Hepatitis C virus replication and pathogenesis

Chung, R.T.; He, W.; Saquib, A.; Contreras, A.M.; Xavier, R.J.; Chawla, A.; Wang, T.C.; Schmidt, E.V., 2001:
Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system

Mazzaro, C.; Panarello, G.; Tesio, F.; Santini, G.; Crovatto, M.; Mazzi, G.; Zorat, F.; Tulissi, P.; Pussini, E.; Baracetti, S.; Campanacci, L.; Pozzato, G., 2000:
Hepatitis C virus risk: A hepatitis C virus related syndrome

Beccari, M.; Rizzolo, L.; Ottolenghi, A.; Sorgato, G., 2002:
Hepatitis C virus screening strategies in haemodialysis units

Hahn, J.A.; Page-Shafer, K.; Lum, P.J.; Bourgois, P.; Stein, E.; Evans, J.L.; Busch, M.P.; Tobler, L.H.; Phelps, B.; Moss, A.R., 2002:
Hepatitis C virus seroconversion among young injection drug users: relationships and risks

Tomiyama, H.; Arai, T.; Hirose, K.I.hi; Hori, S.; Yamamoto, Y.; Yamashina, A., 2003:
Hepatitis C virus seropositivity, but not hepatitis B virus carrier or seropositivity, associated with increased pulse wave velocity

Mendes-Corrêa, M.C.; Barone, A.A.; Guastini, C., 2001:
Hepatitis C virus seroprevalence and risk factors among patients with HIV infection

Dentico, P.; Curatolo, N.; Sacco, R.; D.L.ca, M.; Volpe, A.; Ranieri, C.; Genchi, C.; Petracca, L.; Buongiorno, R., 1999:
Hepatitis C virus serotypes and sources of infection in patients with HCV-related chronic liver disease from one geographical area in Southeast Italy

Dentico, P.; Sacco, R.; Volpe, A.; Ranieri, C.; Carabellese, S.; Carbone, M.; Casalino, C.; Buongiorno, R., 2000:
Hepatitis C virus serotypes in haemodialysis patients in South-East Italy

Sarobe, P.; Lasarte, J.José.; Zabaleta, A.; Arribillaga, L.; Arina, A.; Melero, I.; Borrás-Cuesta, F.; Prieto, Jús., 2003:
Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses

Honda, A.; Arai, Y.; Hirota, N.; Sato, T.; Ikegaki, J.; Koizumi, T.; Hatano, M.; Kohara, M.; Moriyama, T.; Imawari, M.; Shimotohno, K.; Tokuhisa, T., 1999:
Hepatitis C virus structural proteins induce liver cell injury in transgenic mice

Tardif, K.D.; Mori, K.; Siddiqui, A., 2002:
Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway

Liaw, Yun Fan, 2002:
Hepatitis C virus superinfection in patients with chronic hepatitis B virus infection

Gentili, G.; Pisani, G.; Bisso, G.; Cristiano, K.; Wirz, M.; Mele, C., 2001:
Hepatitis C virus testing of plasma pools by nucleic acid amplification technology: External quality assessment

Walker, M.P.; Appleby, T.C.; Zhong, W.; Lau, J.Y.N.; Hong, Z., 2003:
Hepatitis C virus therapies: current treatments, targets and future perspectives

Schüttler, C.G.; Caspari, G.; Jursch, C.A.; Willems, W.R.; Gerlich, W.H.; Schaefer, S., 2000:
Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA

Cody, S.H.; Nainan, O.V.; Garfein, R.S.; Meyers, H.; Bell, B.P.; Shapiro, C.N.; Meeks, E.L.; Pitt, H.; Mouzin, E.; Alter, M.J.; Margolis, H.S.; Vugia, D.J., 2002:
Hepatitis C virus transmission from an anesthesiologist to a patient

Humpe, A.; Legler, T.J.; Nübling, C.M.; Riggert, J.; Unger, G.; Wolf, C.; Heermann, K.H.; Köhler, M., 2000:
Hepatitis C virus transmission through quarantine fresh-frozen plasma

Rispeter, K.; Lu, M.; Behrens, S.E.; Fumiko, C.; Yoshida, T.; Roggendorf, M., 2000:
Hepatitis C virus variability: sequence analysis of an isolate after 10 years of chronic infection

George, S.L.; Gebhardt, J.; Klinzman, D.; Foster, M.B.; Patrick, K.D.; Schmidt, W.N.; Alden, B.; Pfaller, M.A.; Stapleton, J.T., 2002:
Hepatitis C virus viremia in HIV-infected individuals with negative HCV antibody tests

Qiu, P.; Cai, X.Y.n; Wang, L.; Greene, J.R.; Malcolm, B., 2002:
Hepatitis C virus whole genome position weight matrix and robust primer design

Baldo, V.; Floreani, A.; Menegon, T.; Grella, P.; Paternoster, D.M.; Trivello, R., 2000:
Hepatitis C virus, hepatitis B virus and human immunodeficiency virus infection in pregnant women in North-East Italy: A seroepidemiological study

Mazzaro, C.; Efremov, D.G.; Burrone, O.; Pozzato, G., 1998:
Hepatitis C virus, mixed cryoglobulinaemia and non-Hodgkin's lymphoma